bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Conserved epigenetic regulatory logic infers genes governing cell identity
Woo Jun Shim1,13, Enakshi Sinniah2,13, Jun Xu2, Burcu Vitrinel3, Michael Alexanian4, Gaia Andreoletti5,
Sophie Shen2, Brad Balderson1, Guangdun Peng6,7, Naihe Jing6,7, Yuliangzi Sun2, Yash Chhabra8, Yuliang
Wang9, Patrick P L Tam10, Aaron Smith8, Michael Piper11,12, Lionel Christiaen3, Quan Nguyen2, Mikael
BodÃ©n1,*, Nathan J. Palpant2,11,*
1

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia

2

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia

3

Center for Developmental Genetics, Department of Biology, New York University, New York, NY, USA

4

The Gladstone Institute, University of California San Francisco, San Francisco, CA, USA

5

Institute for Computational Health Sciences, University of California, San Francisco, CA 94158, USA

CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese
Academy of Sciences, University of Chinese Academy of Sciences, Guangzhou 510530, China; and Guangzhou
Regenerative Medicine and Health GuangDong Laboratory (GRMH-GDL), Guangzhou 510005, China.
6

State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of
Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, 320
Yueyang Road, Shanghai, 200031, China
7

Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of
Technology, Brisbane, Australia
8

9

University of Washington, Department of Computer Science, Seattle, WA, USA

The University of Sydney, Childrenâ€™s Medical Research Institute, and School of Medical Sciences, Faculty of
Medicine and Health, Westmead NSW 2145 Australia

10

11

School of Biomedical Sciences, The University of Queensland, Brisbane, Australia

12

Translational Research Institute, Woolloongabba, Brisbane, Australia

13

These authors contributed equally to this work

*

Co-senior and co-corresponding authors

Contact information:
Mikael BodÃ©n
School of Chemistry and Molecular Biology
The University of Queensland
Brisbane, Australia
T: 61 07 336 51307
E: m.boden@uq.edu.au

Nathan Palpant
Institute for Molecular Bioscience
The University of Queensland
Brisbane, Australia
T: 61 0439 241 069
E: n.palpant@uq.edu.au

1

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

ABSTRACT
We define a scalable and genome-wide metric based on the gene-repressive tri-methylation of histone 3
lysine 27 that strongly enriches for genes that drive cell diversification and determine their fates.
Transcriptional Regulatory Inference Analysis from Gene Expression (TRIAGE) incorporates tendencies
of H3K27me3 as deposited across over 100 representative cell states. As a consequence, inference of cell
identity genes from expressed transcripts of any somatic cell type is made possible without requiring its
correlative epigenetic data. We combine more than 1 million genome-wide data sets from different omics
platforms to identify and experimentally validate cell type-specific regulatory mechanisms for organ
systems in health and disease. The success with which driver genes are recovered attests to a repressionbased regulatory logic conserved in species across the animal kingdom, and suggests a simple but
effective computational approach to determine causal factors from gene output alone.

2

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

INTRODUCTION
Genetic regulation of cellular identity during differentiation and homeostasis is governed by highly
conserved epigenetic regulation of chromatin states. Recent technological advances are enabling the
capture of genome-wide information at the level of a single cells, providing an unprecedented level of
detail into mechanisms of cellular identity. However, using genome-wide analyses of cellular states to
identify regulatory cell identity programs is challenging due to the high abundance of structural and
house-keeping genes. For this reason, predicting regulatory determinants of cell identity from genomic
data involves cross-referencing between multiple data sets from complementary technologies1-3 and
remains an ongoing and essential strategy for gleaning novel insights into developmental biology, disease
mechanisms and cellular reprogramming1,4,5.
The breadth of histone modifications (HMs) has been shown to be structurally and functionally linked to
cell-specific genome architecture and gene regulation1,2,6-8. For example, broad domains of H3K4me3
preferentially mark actively transcribed drivers of cell identity1 and broad domains of repressive
H3K27me3 are deposited over transcriptionally inactive drivers of cell identity2,9. Indeed, H3K27me3
functionally represses transcription10,11 and therefore plays an essential juxtaposing role to H3K4me31 and
H3K27ac12 in regulating gene expression. Computational approaches incorporating genome-wide
chromatin and transcriptional data have utilized these genomic features to predict the regulatory and cellspecific elements of cells1-3,13. We utilized histone methylation and transcriptional data from a diverse
spectrum of cell states to evaluate genome-wide transcriptional features of genes safe-guarding cell
identity to establish a computational logic that can be customized to infer regulatory drivers of any cell.
Here, we show the a priori probability of broad H3K27me3 domains signifies a repressive tendency of a
gene in diverse cell states. This provides a quantifiable metric strongly predictive of regulatory genes
governing mechanisms of cell differentiation and organ morphogenesis in health and disease. It defines a
metric of gene regulatory potential that can be applied at scale to any quantitative readout of gene
expression from theoretically any cell-state in an analysis termed TRIAGE (Transcriptional Regulatory

3

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Inference Analysis of Gene Expression). We demonstrate that TRIAGE can be used to analyze individual
transcriptomes of millions of heterogeneous cells simultaneously to infer the cell type-specific regulatory
genes driving somatic cell states across diverse species in the animal kingdom. With new capabilities in
studying the genetic state of individual cells, these insights will potentially transform our capacity to
understand the mechanistic basis of cellular heterogeneity in health and disease.
RESULTS
Broad histone domains demarcate genes with distinct regulatory roles
We took the approach that the genome is equivalent to an information source that can exist in a
continuum to derive a theoretically infinite number of specific cell states. To predict the regulatory
determinants of one state, information about the genome from diverse cell states is required to infer how
variations in genome activity deliver biological complexity. We used NIH Epigenome Roadmap data14,
which contains ChIP-seq data for H3K4me3, H3K36me3, H3K27me3, H3K4me1, H3K27ac and
H3K9me3 for 111 tissue or cell types (Supplementary Table 1). To associate HM domains with
proximal regulatory functions governing gene expression, we linked HM domains within 2.5 kb to known
transcriptional start sites of RefSeq genes. For each of the six HMs, genes were annotated based on the
broadest HM domain linked to the gene. For each HM, we found that the top 100 genes with the broadest
domain were remarkably consistent between cell types (Fig. 1a), however, broad domains of different
HMs marked distinct sets of genes (Supplementary Fig. 1a). We further noted that genes marked with
broad repressive HMs (i.e. H3K9me3 or H3K27me3) were more consistently shared between cell types
than genes marked by other HMs (Fig. 1a, inset) suggesting that broad repressive chromatin domains
comprise a common strategy for epigenetic control of cell diversification.
We aimed to understand how the breadth of histone domains correlate with genes governing cell identity.
To this end, we established a broadly applicable positive gene set for cell type-specific regulatory genes
comprised of 634 variably expressed transcription factors (VETFs) having a coefficient of variation

4

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

greater than 1 (Supplementary Table 2) across 46 NIH Epigenome RNA-seq data sets14,15. We used
Shannon entropy to quantify cell type specificity16 and demonstrate that VETFs are significantly more
cell type-specific, compared to non-VETFs or protein coding genes. Analysis of RNA-seq data sets from
diverse cell and tissue types show that VETFs in each sample reflect appropriate tissue or cell typespecific regulatory functions (Figs. 1b,c inset). Henceforth, VETFs provide a positive gene set where
their enrichment is a performance metric for identifying cell type-specific regulatory genes.
We utilized VETFs to determine the relationship between cell type-specific regulatory genes and histone
broad domains. To this end, all NIH Epigenome histone ChIP-seq data were ranked by domain breadth,
comprising greater than thirteen million peaks, and analyzed using Fisherâ€™s exact test to assess
enrichment of VETFs. These data show that H3K27me3 uniquely enriches for VETFs within the top 5%
of broad domains (Fig. 1c), while repression of VETFs was significantly correlated with breadth of
H3K27me3 domains (Supplementary Fig. 1b). We also showed that genes frequently associated with
broad H3K27me3 domains involve various morphogenic and developmental processes (Fig. 1d). Taken
together, we demonstrate that quantification of H3K27me3 broad domains from diverse cell and tissue
types provides a powerful metric to reproducibly enrich for cell type-specific regulatory genes governing
the biological complexity of diverse cell states.
To illustrate the distinctive enrichment of H3K27me3 in regulatory genes as opposed to structural or
housekeeping genes17, we extracted expression and chromatin data from cardiomyocytes (Figs. 1e,f). We
show that the transcript abundance of cardiac regulatory genes (i.e. GATA4, GATA6, NKX2-5, TBX5 and
TBX20) and structural sarcomere genes (i.e. MYH6, MYH7, MYL2, MYL3 and TNNI3) are all significantly
elevated in cardiac cells compared to other cell types, but cannot be distinguished as regulatory or
structural genes except by differential expression (Fig. 1e). Furthermore, focusing on H3K27me3 of only
the cardiomyocyte samples is uninformative in distinguishing structural from regulatory genes because
these genes all lack repressive chromatin. In contrast, in all cell types except the heart, H3K27me3
domains broader than 30kb consistently identify cardiac regulatory genes from structural genes (Fig. 1e).

5

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

No other HM analyzed demarcates cell type-specific regulatory genes from structural genes in this
manner (Fig. 1f, Supplementary Fig. 1c), establishing the rationale that the frequency of H3K27me3
across heterogeneous cell types provides a novel strategy to infer the likelihood of a gene having cell
type-specific regulatory function.
Cell type-specific regulatory genes tend to be marked by broad H3K27me3 domains
We established a simple, quantitative logic that leverages the significance of broad H3K27me3 domains
for distinguishing regulatory genes. Deposition of broad H3K27me3 domains allows for setting the
default gene activity state to â€œoffâ€ such that cell type-specific activity occurs by rare and selective
removal of H3K27me3 while all other loci remain functionally repressed10,18. Conversely, genes with
housekeeping or non-regulatory roles rarely host broad H3K27me3 domains. We calculated for each gene
in the genome across 111 NIH epigenome cell and tissue types (i) the sum of breadths of H3K27me3
domains in base-pairs and multiplied this by (ii) the proportion of cell types in which the geneâ€™s
H3K27me3 breadth is within the top 5% of broad domains (Fig. 2a). This approach quantifies a single
value for every gene that defines its association with broad H3K27me3 domains which we call its
repressive tendency score (RTS) (Supplementary Table 3). Using the NIH Epigenome Roadmap data,
the RTS is calculated for 99.3% (or 26,833 genes) of all RefSeq genes. To demonstrate that our
formulation is agnostic to the composition of cell types, we note that for all genes, the RTS is within one
standard deviation of the mean of bootstrapping empirical distribution derived from 10,000 re-samplings
of cell types. We note that the 111 cell types provided sufficient sample size to calculate a stable RTS
independent of the peak calling method to define H3K27me3 domains (Supplementary Figs. 2a,b,e,f),
with over 85% of assigned H3K27me3 domains overlapping only a single protein-coding gene
(Supplementary Fig. 2d). The RTS only requires sufficient subsampling of H3K27me3 from any diverse
collection of cell states to establish a stable metric.
Using RTS values above the inflection point (RTS>0.03022) of the interpolated RTS curve, we identified
a priority set of 1,359 genes that show a significant enrichment for genes underlying cellular
6

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

diversification including organismal development, pattern specification and multicellular organismal
processes (Fig. 2b), and show they are cell type-specific (Fig. 2c) and lowly expressed (Fig. 2d). Among
the 1,359 priority genes, we identified enrichment of regulatory gene sets, including 253 VETFs (Fig. 2e,
p=3.49e-162, Fisherâ€™s exact test, one-tailed) in addition to 157 homeobox proteins19 (p=6.43e-123). The
gene set also includes 260 genes involved in at least one KEGG pathway20 and 291 non-coding RNAs
genes including FENDRR and HOTAIR, regulators of heart development and chromatin dynamics
respectively21,22. We also demonstrate that genes with a high RTS are enriched in key regulators of
processes underlying gastrulation and organ morphogenesis, comprise members of many of the major
signaling pathways, as well as genes implicated in pathologies including cardiovascular disease, diabetes,
neurological disorders and cancer (Fig. 2f and Supplementary Table 4). Taken together, these data
indicate that ranking based on a geneâ€™s repressive tendency generates a simple and effective strategy to
enrich for fundamental genetic determinants of biological complexity of cell states underlying health and
disease.
Predicting cell type-specific regulatory genes based on H3K27me3
The transcriptome of a cell derives from a fraction of the genome comprising expression of structural,
housekeeping and regulatory genes collectively representing the cellâ€™s state. The regulatory genes
controlling the identity, fate and function of a cell, such as transcription factors (TFs), are a minor fraction
of the transcriptome, and are non-trivial to identify due to their typical low abundance. Furthermore,
regulatory genes are difficult to identify without drawing on prior knowledge, utilizing external reference
points, or implementing other supervised methods. To address this, we established a mechanism for
integrating genome-wide RTS values with cell type-specific transcriptomic data. Since every gene is
assigned a fixed RTS value that hierarchically orders the genome based on regulatory likelihood, we
devised a computational approach to integrate the signature of any cellâ€™s transcriptomic data with the
RTS, a method we call TRIAGE (Transcriptional Regulatory Inference Analysis from Gene Expression).

7

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

For any gene i the product between a geneâ€™s expression (ğ‘Œğ‘Œğ‘–ğ‘– ) and repressive tendency (ğ‘…ğ‘…ğ‘–ğ‘– ) gives rise to its

discordance score (ğ·ğ·ğ‘–ğ‘– ) as defined by:

ğ·ğ·ğ‘–ğ‘– = ln (ğ‘Œğ‘Œğ‘–ğ‘– + 1) âˆ™ ğ‘…ğ‘…ğ‘–ğ‘–

The discordance score (DS) reflects the juxtaposition of a geneâ€™s association with being epigenetically
repressed and the observed transcriptional abundance of that gene in the input data. TRIAGE introduces a
non-linear, gene-specific weight (i.e. RTS) that prioritizes cell type-specific regulatory genes from
expression data derived from any cellular state (Fig. 3a, Supplementary Figs. 2c, 3a, 3b). Importantly,
this strategy does not refer to any external data set, uses no arbitrary statistical cutoffs, does not require
additional cell type-specific epigenetic data, does not focus on a specific gene type such as TFs, nor does
it utilize external databases or prior knowledge to derive its prediction.
To evaluate TRIAGE, we identified known regulatory and structural genes from 5 tissue groups,
analyzing H3K27me3 of cell-specific regulatory versus structural genes (Fig. 3b). When applied to cellspecific transcriptional data, TRIAGE effectively reduces the relative abundance of structural and
housekeeping genes, while enriching for regulatory genes in a cell type-specific manner (Fig. 3c). Taken
to scale, TRIAGE transformation of all 46 Roadmap samples results in enrichment of tissue or cell typespecific TFs among the top 1% in every cell type exhibiting functional specificity unique to the input
sample (Fig. 3d and Supplementary Fig. 3c). Compared to the expression-based ranking, TRIAGE
reduces the relative abundance of housekeeping genes (Fig. 3d). A tanglegram based on the Pearson
distances between Roadmap tissue types23 shows that relative to the total height of the dendrograms,
TRIAGE increased the similarity between samples from the same tissue by ~29% when compared to
distances calculated using absolute expression levels (Supplementary Fig. 3d).
We subsequently evaluated TRIAGE against methods utilizing epigenetic data such as H3K4me31,
H3K27me32 and markers for super-enhancers8,24 to predict cell regulatory genes. These previous
approaches require input cell type-specific data for HMs therefore significantly limiting their scalability.

8

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Even when allowing for this, TRIAGE surpassed all other methods in terms of both sensitivity and
precision across diverse tissue types (Fig. 3e, f, Supplementary Figs. 4a-d). TRIAGE also outperforms
routine approaches such as differentially expressed gene (DEG) analysis which is susceptible to variation
based on the comparison point (Fig. 4f, Supplementary Figs. 4g,h). Lastly, we show that TRIAGE
predictions are not explained merely by prioritising TFs (Supplementary Figs. 4g) and does not simply
recover lineage-specific genes based on the loss of H3K27me3 during development (Supplementary
Figs. 4e,f). Compared to alternative approaches, TRIAGE provides a powerful new strategy to recover
unique regulators of cell identity that is largely non-overlapping with previous tested strategies
(Supplementary Fig. 4i).
Identifying cell type-specific regulatory genes from any chordate somatic cell type
Regulatory genes underlying cell identity during development are evolutionarily conserved. Using interspecies gene mapping, we tested whether TRIAGE could identify regulatory drivers of heart development
across diverse chordate species including mammals (i.e. Homo sapiens, Mus musculus, and Sus scrofa),
bird (Gallus gallus), fish (Danio rerio) and invertebrate tunicate (Ciona robusta) (Fig. 3g). In contrast to
expression alone, TRIAGE recovered cardiac regulatory genes with high efficiency across all species.
More broadly, we used TRIAGE to enrich for relevant tissue morphogenesis biological processes from
diverse cell types and species including arthropods (Fig. 3h). While TRIAGE is currently devised using
human epigenetic data, this suggests that TRIAGE can be used to identify regulatory genes from cell
types that are conserved across the animal kingdom.
Dissecting the mechanistic basis of cell heterogeneity at single cell resolution
Recent developments in barcoding and multiplexing have enabled scalable analysis of thousands to
millions of cells25. Determining mechanistic information from diverse cell states captured using singlecell analytics remains a challenge. TRIAGE is scalable for studies of cell heterogeneity because it

9

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

requires no external reference points and therefore provides a distinctive advantage for identifying
regulatory control mechanisms one cell transcriptome at a time.
To illustrate this, we analyzed 43,168 cells captured across a 30 day time-course of in vitro cardiacdirected differentiation from human pluripotent stem cells (hPSCs)26. Analysis of day-30 cardiomyocytes
using standard expression data show that high abundance genes are dominated by housekeeping and
sarcomere genes, whereas TRIAGE efficiently identifies regulatory genes governing cardiomyocyte
identity including NKX2-5, HAND1, GATA4, IRX4 within the top 10 most highly ranked genes (Figs.
4a,b). Importantly, TRIAGE retains highly expressed cell-specific structural genes providing an
integrated readout of genes involved in cell regulation and function (Fig. 4c). We used TRIAGE to
convert the genes-by-cells matrix comprising ten different subpopulations spanning developmental stages
including gastrulation, progenitor and definitive cell types (Fig. 4d). In contrast to expression data, which
significantly enriches for structural and housekeeping genes, TRIAGE consistently identifies gene sets
associated with developmental regulation of diverse and biologically distinct subpopulation through
differentiation (Fig. 4e, Supplementary Fig. 5). We show that differential expression results in variable
outcomes depending on the comparison cell type and consistently under-performs against TRIAGE,
which identifies population-specific regulatory genes without external reference comparisons (Fig. 4f).
Predicting regulatory drivers of cell identity using any genome-wide analysis of gene expression
The simplicity of TRIAGE facilitates its use as a scalable application. We used VETFs as a positive gene
set to test enrichment of regulatory genes across millions of diverse cell types by plotting the rank
position of the peak significance (âˆ’log10 ğ‘ğ‘) value in a Fisherâ€™s exact test. Using tabula muris data of

nearly 100,000 cells from 20 different mouse tissues at single-cell resolution27, TRIAGE consistently
enriches for cell type-specific regulatory genes compared to original expression with no difference

between droplet and smartseq2 data sets (Fig. 4g and Supplementary Table 5). Using the mouse
organogenesis cell atlas (MOCA), which is among one of the largest single cell data sets generated to
date25, we demonstrated that TRIAGE outperformed the expression value alone in prioritizing cell type10

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

specific regulatory genes across more than 1.3 million mouse single-cell transcriptomes (Wilcoxon ranksum test for both median significance and rank, p<2.2e-16, one-tailed, Fig. 4h). Lastly, we used
benchmarking data to evaluate clustering accuracy based on ground truth28 to assess the performance of
TRIAGE using three independent algorithms (i.e. CORE, sc3, and Seurat) and show no difference in
accurately assigning cells to the reference (ARI > 0.98) using original expression or TRIAGE transformed
expression (Fig. 4i).
We hypothesized that TRIAGE could be used to study any genome-wide quantitative measurement of
gene expression. To test this, TRIAGE was applied using diverse quantitative readouts of gene expression
across hundreds of different cell types. TRIAGE vastly outperforms original abundance metrics when
measuring chromatin methylation for H3K36me3, a surrogate of RNA polymerase II activity deposited
across gene bodies6 collected from the 111 Roadmap samples (Fig. 4j). Similarly, cap analysis of gene
expression (CAGE), which measures genome-wide 5â€™ transcription activity, showed significant
enrichment of VETFs using TRIAGE from 329 selected FANTOM5 CAGE samples (Fig. 4j and
Supplementary Table 1)29. Lastly, analysis of a draft map of the human proteome shows that TRIAGE
enriches for regulatory drivers of 30 different tissue types from high resolution Fourier transform mass
spectrometry data30 (Fig. 4j). Taken together, these data illustrate the power of utilizing TRIAGE to
predict regulatory drivers of cell states using diverse genome-wide multi-omic endpoints.
Determining the regulatory control points of disease
Strategies for identifying genetic determinants of disease have the potential to guide strategies for
predicting or altering the natural course of disease pathogenesis. We analyzed genetic data from
melanoma and heart failure (HF) pathogenesis to determine the utility of TRIAGE in identifying
regulatory determinants of disease.
Treatment for melanoma has improved with the advent of drugs targeting proliferative cells, but highly
metastatic and drug resistance subpopulations remain problematic. To assess the potential for TRIAGE

11

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

for informing disease mechanisms, we analyzed single cell RNA-seq data from 1,252 cells capturing a
transition from proliferative to invasive melanoma31. Among the top ranked genes, TRIAGE consistently
outperforms expression in prioritizing genes with known involvement in melanoma proliferation and
invasion (Fig. 5a). Using independently derived positive gene sets for proliferative versus invasive
melanoma31,32, TRIAGE recovers with high sensitivity the genetic signatures of these two cancer states
(Fig. 5b). Gene set enrichment analysis using TRIAGE identified ETV5 and TFAP2A associated with
proliferative melanoma versus TFAP2C and TBX3 as regulators of invasive melanoma (Fig. 5c and
Supplementary Table 6). TFAP2A and TBX3 have been implicated in proliferative and invasive
melanoma respectively33,34, whereas ETV5 and TFAP2C were novel predicted regulators. To validate this,
we used in vitro nutrient restriction of melanoma cells to trigger a transition into an invasive phenotype35.
In contrast to expression dynamics of MITF, a master regulator of melanocytic differentiation, and
TFAP2C is upregulated together with AXL, a receptor tyrosine kinase associated with therapeutic
resistance and transition to invasive melanoma (Figs. 5d,e). Further genetic studies are required to
determine the functional role of TFAP2C in governing invasive melanoma.
We next aimed to assess whether TRIAGE could identify transcriptional signatures of therapeutic
interventions in heart failure (HF). Previous studies have shown that the epigenetic reader protein BRD4,
a member of the BET (Bromodomain and Extra Terminal) family of acetyl-lysine reader proteins,
functions as a critical chromatin co-activator during HF pathogenesis that can be pharmacologically
targeted in vivo36,37 to prevent and treat HF by targeting gene programs linked to cardiac hypertrophy and
fibrosis37. We analyzed RNA-seq data from adult mouse hearts where pre-established HF (transverse
aortic constriction, TAC) was treated with JQ1. TRIAGE prioritized TFs and regulatory genes with
known roles in HF pathogenesis (Fig. 5f), outperforming expression ranked genes based on stressassociated gene sets (Fig. 5g). Importantly, comparison between Sham, TAC and TAC+JQ1 TRIAGEbased ranked genes highlighted a potent anti-fibrotic effect of JQ1 without the use of a canonical
differential expression analysis (Fig. 5g). Collectively, these data demonstrate the use of TRIAGE as a
scalable strategy for studying the mechanistic basis of disease aetiology and therapy.
12

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Identification of novel regulatory drivers of development
Lastly, we set out to demonstrate that TRIAGE can facilitate discovery of novel regulatory genes
governing development in vitro and in vivo. Using data from single cell analysis of cardiac
differentiation26 we analyzed mesendoderm sub-populations at day 2. TRIAGE identified known
regulatory genes governing sub-population identity among the top 10 highly ranked genes (Fig. 6a).
Among the TRIAGE identified genes was SIX3, a member of the sine oculis homeobox transcription
factor family (RTS=0.54) (Figs. 6a,b). Importantly, all pairwise differential expression analyses failed to
enrich for SIX3 (Supplementary Fig. 6a). Though the role of SIX3 in neuroectoderm specification has
been studied extensively, little is known about its role in other germ layer derivatives38-40. Analysis of
SIX3 in hPSC in vitro cardiac differentiation shows robust expression in day 2 definitive endoderm (DE)
(28.7%) and mesoderm (37.5%) cell populations (Fig. 6c) with enrichment of SIX3+ cells associated with
definitive endoderm (Supplementary Figs. 6b,c). Using previously published laser microdissection
approaches, we captured the spatiotemporal transcriptional data from germ layer cells of mid-gastrula
stage (E7.0) embryos41, with an expanded analysis to include pre- (E5.5-E.6.0), early- (E6.5) and lategastrulation (E7.5) mouse embryos (Supplementary Fig. 6f). Spatio-temporal expression of SIX3 and
other family members is observed in the epiblast and neuroectoderm, (Fig. 6d, Supplementary Fig. 6g)
consistent with its known role in these lineages38-40, as well as early endoderm lineages (Fig. 6d).
Supporting this finding, SIX3 has been identified as a gene distinguishing definitive from visceral
endoderm42 but no functional studies have validated this finding.
We established CRISPRi loss-of-function hPSCs in which SIX3 transcription is blocked at its CAGEdefined transcription start site (TSS) in a dox-dependent manner (Figs. 6e,f). Cells were differentiated
using monolayer cardiac differentiation and analyzed at day 2 (Fig. 6g). SIX3 loss-of-function depleted
endoderm and mesendoderm genes (Fig. 6h) consistent with FACs analysis showing depletion of
CXCR4+/EPCAM+ endoderm cells (Figs. 6i-k, Supplementary Fig. 6d, Supplementary Fig. 7). In
contrast, FACs analysis of alpha-actinin+ cardiomyocytes showed no difference between SIX3-knockdown

13

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

cells compared to dox-treated controls indicating that loss of SIX3 does not impact mesodermal fates
(Figs. 6l-n, Supplementary Fig. 6e). Taken together, these data demonstrate a novel role of SIX3 in
governing endoderm differentiation.
We also used TRIAGE to identify novel developmental regulators in a distant chordate species, Ciona
robusta. RNA-seq data comprising cell subpopulations captured across a time-course of cardiac
development were analyzed with TRIAGE using a customized gene mapping tool to link human to Ciona
genes (Fig. 6o)43. The top ranked genes based on TRIAGE were analyzed (Fig. 6p). RNF220 (RTS=0.30,
Fig. 6q), an E3 ubiquitin ligase governing Wnt signaling pathway activity through Î²-catenin
degradation44, was identified as a novel regulatory gene not previously implicated in cardiopharyngeal
development. Utilizing CRISPR control vs. RNF220-knockout, we demonstrate that Mesp lineage
progenitors of control animals form the expected ring of pharyngeal muscle progenitors around the atrial
siphon placode, whereas RNF220-knockout embryos showed significant morphogenetic defects.
Collectively, these data illustrate that TRIAGE efficiently identifies novel functional regulatory
determinants as a demonstration for discovering novel biology underlying mechanisms of development.

DISCUSSION
Understanding the genetic determinants of cell diversity is essential for establishing mechanisms of
development, disease etiology and organ regeneration, as well as synthetic control of cell states including
cell reprogramming. Recent advances in deriving genome-wide data at single cell resolution25,27 as well as
computational analysis and prediction algorithms1,4,5,13,45 have revolutionized our capacity to study
complex biological systems and understand the genomic basis of mechanisms governing cell identity1,2,7,8.
Here, we take advantage of the logic that the selective absence of broad H3K27me3 domains at promoters
across diverse cell states establishes a fixed metric that predicts cell identity genes. By drawing on the
diverse cell types and epigenetic states recorded in consortium data sets, such as that hosted by the NIH
Roadmap Epigenomics project14, we calculate the direct relationship between core histone methylation
14

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

signatures and cell-specific regulatory genes. TRIAGE was designed to provide a scalable prediction
metric and therefore focused on the main (and most confident) association between H3K27me3 domains
and their protein-coding genes. Furthermore, focusing on protein coding genes provided a means for
expanding its utility to cross-genome generalisations of the score by mapping to orthologous genes in
other species. From this we define a, surprisingly simple, repressive tendency score based on H3K27me3
broad domains to identify cell type-specific regulatory genes underlying cell diversification in
development and disease. We demarcate a priority gene-set of 1,359 genes consistently regulated by
broad H3K27me3 domains across major cell lineages; we find that they represent key cell type specific
drivers of germ layer diversification in development and control points of disease pathogenesis across
diverse species.
We show that the genome-wide repressive tendency score of a gene can interface with any customized
input data quantitatively measuring transcriptional activity of a cell including RNA-seq, proteomics,
CAGE-seq and H3K36me3 tag density to effectively capture cell type-specific regulatory genes. In
contrast to previous inference strategies4,5, TRIAGE does not utilize comparative reference points nor any
external metadata for its predictions and can be applied to data from theoretically any somatic cell type
and animal phyla. In fact, TRIAGE performs convincingly against alternative formulations based on
H3K4me3 domain breadth1, super-enhancers8,12,24, differential gene expression and functional
heterogeneity (FH) score2 across different biological contexts. We build on the prevailing view that
epigenetic states guide regulatory processes; we note that while TRIAGE incorporates a single repressive
mark mapped to transcription start sites of protein coding genes, it effectively identifies regulatory drivers
with high sensitivity and precision.
While sufficiently diverse data sets on epigenetic control of cell states are currently available only for
human and mouse, we show that the evolutionary conservation of gene regulation enables this
quantitative strategy to predict regulatory genes across diverse species in the animal kingdom. We
hypothesize that this approach can be applied across diverse cell and tissue types in species where gene

15

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

expression is governed by the polycomb group complex-2 (PRC2). While not perfectly conserved through
evolution, PRC2 and its regulation of histone methylation are known to govern genes in protists, animals,
plants, as well as fungi46. Indeed, zebrafish47 and medaka9 genes with broad H3K27me3 deposition at
promoter sites encode master developmental regulators overlapping with those found in our study. This
illustrates the conservation of PRC2-mediated H3K27me3 regulation and repression of genomic loci
across species and its role in safeguarding cell identity10,48. We note that cross-species applications are
limited by gene mapping tools and the composition of cellular diversity that distinguishes animal phyla.
The application of TRIAGE to single cell resolution genomic data yields novel insights into the
regulatory basis of heterogenous cell populations. With each transcriptome evaluated independently,
TRIAGE effectively prioritizes cell-specific regulators of identity including TFs and signaling molecules,
despite their low abundance in transcriptomics analyses. Importantly, TRIAGE prioritization of
regulatory mechanisms governing cell states enables effective prediction of drivers of cell identity in a
population-specific manner, providing a basis for cell type identification and an effective strategy for
novel biological discovery.
The conservation of epigenetic regulatory logic of the genome provides an effective strategy for utilizing
large, diverse genome-wide data to establish quantitative principles of cell states to infer cell type-specific
mechanisms that explain the complexity of biological systems. We anticipate that this analytic approach
can render customized inference predictions, based on chromatin transition, between diverse healthy and
diseased tissues to reveal stress-sensitive loci and novel disease drivers. This conceptual and experimental
framework can infer regulatory genes governing theoretically any cell state and has broad utility for
studies in genome regulation of cell identity in health and disease.

16

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

METHODS
Data sets. We used broad peak representations for 6 different histone modifications, namely H3K4me1,
H3K4me3, H3K9me3, H3K27me3, H3K27ac and H3K36me3, for 111 human cell types from the NIH
Roadmap database14. We used identifiers from Animal TFDB and DBD to identify 1,605 human TFs49,50.
We also identified 3,804 housekeeping genes from the published literature17.

For performance evaluation of TRIAGE, we selected 5 distinct tissue-groups; (i) Brain, (ii) Lung, (iii)
Pancreas, (iv) Skeletal muscle and (v) Heart. We used transcriptomic abundance as well as HM ChIP-seq
data from the Roadmap; Brain germinal matrix (E070) for the brain, Lung (E096) for the lung, Pancreas
(E098) for the pancreas, Psoas muscle (E100) for the skeletal muscle and a published data set for cardiac
progenitor cells for the heart (GSE97080)13. We also used GTEx expression profiles of samples that
belongs to the 5 tissue-groups51. The GTEx database provides a large number of sample transcriptomes
covering a wide range of tissue-groups. We downloaded expression profiles of all available samples for
the 5 selected tissue groups; 417 samples from the left ventricle (Heart), 195 samples from the cortex
(Brain), 268 samples from the pancreas (Pancreas), 607 samples from the lung (Lung) and 718 samples
from the skeletal muscle (Skeletal muscle). We averaged gene expression values of samples for each
tissue-group.

To define a gene set regulating a given cell fate, we used gene ontology (GO) annotation data52. We
identified TFs with a relevant GO biological process (BP) term as the regulatory gene set. We chose the
GO term to not only represent the identity of the tissue type but also to capture a spectrum of relevant
regulatory genes. For instance, we used â€˜heart developmentâ€™ term (GO:0007507) to select a set of TFs
specific for the heart development. Similarly, â€˜brain developmentâ€™ (GO:0007420), â€˜lung developmentâ€™
(GO:0030324), â€˜pancreas developmentâ€™ (GO:0031016) and â€˜muscle structure developmentâ€™
(GO:0061061) GO terms were used to collect regulatory gene sets for the brain, lung, pancreas and

17

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

skeletal muscle samples, respectively (Supplementary Table 2). We identified expressed (i.e. RPKM>1)
regulatory genes in a given input data set as the positive gene set.

Identifying the gene set as a proxy for cell type-specific regulatory genes. Along with TFs with a
tissue-type-specific GO BP term, we identified a gene set that universally represents cell type-specific
regulatory genes. We identified 634 TFs whose expression values shows substantial variation (i.e.
coefficient of variation>1) across the 46 Roadmap cell types and labelled them as variably expressed TFs
(VETFs) (Supplementary Table 2). This classification is based on previous observations that expression
of actively regulated genes is highly variable both temporally and spatially15. While these 634 VETFs
encompass regulatory genes for a broad range of cell and tissue types, we used a subset of these TFs that
were expressed (RPKM>1 or equivalent) in a given input transcriptome as a positive gene set specific for
the input. We show the functional specificity of positive gene sets in different cellular contexts (Fig. 1b)
as well as the expressional specificity (Fig. 1c inset) which is also quantified based on the Shannonâ€™s
entropy. We used these 634 TFs as an effective proxy for cell type-specific regulatory genes.

Quantifying cell type specificity of VETFs. We use Shannon entropy to quantify the specificity of
expression for VETFs, as observed across m=46 Roadmap cell types14,16. The relative expression is
calculated as

ğ‘ğ‘ğ‘–ğ‘–,ğ‘—ğ‘— = ğ‘¤ğ‘¤ğ‘–ğ‘–,ğ‘—ğ‘— / âˆ‘ğ‘šğ‘š
ğ‘˜ğ‘˜=1 ğ‘¤ğ‘¤ğ‘–ğ‘–,ğ‘˜ğ‘˜ where ğ‘¤ğ‘¤ğ‘–ğ‘–,ğ‘—ğ‘— is the expression value of gene i in cell type j
and its cell type specificity is

ğ»ğ»ğ‘–ğ‘– = âˆ’ âˆ‘ğ‘šğ‘š
ğ‘˜ğ‘˜=1 ğ‘ğ‘ğ‘–ğ‘–,ğ‘˜ğ‘˜ âˆ™ log 2 ğ‘ğ‘ğ‘–ğ‘–,ğ‘˜ğ‘˜

18

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

The cell type specificity ranges between 0 (when the gene is uniquely expressed in a single cell type) and
log 2 ğ‘šğ‘š (when the gene is expressed uniformly across all cell types). VETFs had significantly lower

entropies (mean=3.64), compared to non-VETFs (mean=5.25, p=4.31e-230, Wilcoxon rank-sum test, one-

tailed) and all protein-coding genes (mean=4.48, p=1.55e-108).

Association of genes with a histone modification (HM) domain. We used broad peak representation of
consolidated histone modification files obtained from the Roadmap database. To assign peaks (referred to
as domains hereafter) to genes, we used following steps.

1. Defining the proximal region of the gene. We defined a proximal region for each gene. The proximal
region for a gene is the RefSeq gene body plus a region extended by 2.5kb from the TSS in the upstream
direction.

2. Provisional assignment of domains to genes. For each gene, we first identified HM domains with their
center position overlapping the proximal region. These domains were provisionally assigned to the
corresponding gene. Domains that were broad, with their center position outside of the proximal region
were still included if the domain overlapped with any proximal regions of genes, in which case, the
domain was provisionally assigned to all overlapping genes. Suppose that gene i in cell type j have a set
of provisionally assigned domains, ğ·ğ·ğ‘–ğ‘–,ğ‘—ğ‘— = {ğ‘‘ğ‘‘1 , ğ‘‘ğ‘‘2 , â€¦ , ğ‘‘ğ‘‘ğ‘™ğ‘™ , â€¦ } where ğ‘‘ğ‘‘ğ‘™ğ‘™ is the breadth (in base-pairs) of the

l-th domain provisionally assigned to the gene.

3. Final assignment of domains to genes. If multiple domains were assigned to a gene i in cell type j, it is
represented by the breadth of the broadest domain
ğ‘ğ‘ğ‘–ğ‘–,ğ‘—ğ‘— = ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š(ğ·ğ·ğ‘–ğ‘–,ğ‘—ğ‘— )

19

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

We used BEDTOOLS intersect program to assign HM domains to RefSeq genes53. We removed any
intergenic domains that did not overlap any proximal regions of genes to reduce potential bias of
including putative enhancers54.

Our approach to annotate genes with breadth of the broadest H3K27me3 domain did not result in loss of
relevant functional information. To illustrate this point, we calculated correlation between expression
level of a gene and (i) the breadth of the broadest H3K27me3 domain or (ii) the sum of breadths of all
H3K27me3 domains assigned to the gene. When we performed this analysis across all the cell types in
Roadmap, we found no significant difference in the correlation between these two approaches, with the
mean Spearmanâ€™s rho of -0.364 and -0.337 respectively. Furthermore, the majority of domains finally
assigned to protein-coding genes (i.e. approximately 85% of 1,537,514 assigned H3K27me3 domains
across the 111 cell types) overlapped a single gene (Supplementary Fig. 2d). Approximately 66.9% of
all H3K27me3 domains assigned to genes were identified in the RefSeq gene region while remaining
22.6% and 10.5% were in the promoter (+2.5kb from the TSS) and intergenic regions respectively,
indicating that the majority (89.5%) of the assigned H3K27me3 domains were proximal to the gene.
For cell type j, we have a set of HM domain breadth values ğµğµğ‘—ğ‘— = ï¿½ğ‘ğ‘1,ğ‘—ğ‘— , ğ‘ğ‘2,ğ‘—ğ‘— , â€¦ , ğ‘ğ‘ğ‘–ğ‘–,ğ‘—ğ‘— , â€¦ , ğ‘ğ‘ğ‘›ğ‘›,ğ‘—ğ‘— ï¿½ for n genes.

Subsequently, we normalized breadth values to yield the breadth score (h) for all genes across the cell
types, â„ğ‘–ğ‘–,ğ‘—ğ‘— =

ï¿½ï¿½ï¿½ğš¥ğš¥
ğ‘ğ‘ğ‘–ğ‘–,ğ‘—ğ‘— âˆ’ğµğµ
ğ‘ ğ‘ ğ‘—ğ‘—

ï¿½ğš¥ğš¥ and ğ‘ ğ‘ ğ‘—ğ‘— are the sample mean and the standard deviation of HM domain
where ğµğµ

breadths in cell type j.

Genomic locations of H3K27me3 domain. We investigated genomic locations of 1,537,514 H3K27me3
domains used for the RTS calculation. First, we identified a center position of each domain and used
BEDTOOLS intersect program to identify if they overlap with (i) known RefSeq genes or (ii) promoters
(defined as +2.5kb from the RefSeq TSS). If the domain does not overlap any of these, we labelled the
domain as (iii) intergenic.
20

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Defining the broad H3K27me3 domain. We observed that VETFs were strongly associated with broad
H3K27me3 domains across various cell types. When genes were ranked by the breadth of their assigned
H3K27me3 domain, VETFs were most significantly (p=6.66e-16, Fisherâ€™s exact test, one-tailed) enriched
in the top 5% across all cell types (Fig. 1c). Based on this observation, we defined the top 5% broadest
domains for a given cell type as nominally broad. Let ğ‘‹ğ‘‹ğ‘–ğ‘–,ğ‘—ğ‘— indicate whether gene i has a broad H3K27me3
domain in cell type j

ğ‘‹ğ‘‹ğ‘–ğ‘–,ğ‘—ğ‘— = ï¿½

1, ğ‘–ğ‘–ğ‘–ğ‘– ğ‘¡ğ‘¡â„ğ‘’ğ‘’ ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ ğ»ğ»3ğ¾ğ¾27ğ‘šğ‘šğ‘šğ‘š3 ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ ğ‘–ğ‘–ğ‘–ğ‘– ğ‘–ğ‘–ğ‘–ğ‘– ğ‘¡ğ‘¡â„ğ‘’ğ‘’ ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ 5%
0, ğ‘œğ‘œğ‘œğ‘œâ„ğ‘’ğ‘’ğ‘’ğ‘’ğ‘’ğ‘’ğ‘’ğ‘’ğ‘’ğ‘’ğ‘’ğ‘’

Similarity analysis on genes with broad HM domains. To understand similarity of genes with broad HM
domains across cell types, we first assigned genes to HM domains of 6 different types. For each HM type
and each cell type, genes were ranked by the breadth of the assigned domain and grouped into bins of 100
genes. Jaccard similarity index was calculated at each rank bin between all pairs of cell types.

Identification of genes frequently associated with broad HM domains. To identify genes that are
frequently associated with the broad HM domain across the Roadmap cell types, we counted the number of
cell types where a given gene was associated with the broad HM. We ranked genes by the count and
identified the top 200 genes for each HM type for downstream analysis.

Estimating epigenetic repressive tendency of the gene. We hypothesized that the regulatory importance
of a gene in any cell type can be determined from evidence of (i) expression level of that gene in the same
cell type, and (ii) breadth of H3K27me3 domains collected from a diverse range of cell types. To test this,
we proposed a method that first quantifies the association of a gene with the H3K27me3 domain. For each
gene, the method considers (i) a sum of H3K27me3 breadth scores for the gene calculated from m cell types
21

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

(e.g. 111 Roadmap cell types) and (ii) the number of cell types where the gene is associated with a broad
H3K27me3 domain. For gene i, sum of the breadth scores (ğ‘£ğ‘£ğ‘–ğ‘– ) is defined as follows.
ğ‘šğ‘š

ğ‘£ğ‘£ğ‘–ğ‘– = ï¿½ â„ğ‘–ğ‘–,ğ‘˜ğ‘˜
ğ‘˜ğ‘˜=1

The sum of breadth scores was then re-scaled into a range from 0 to 1 (ğ‘£ğ‘£ğ‘–ğ‘– â€²) as follows, where ğ‘£ğ‘£ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š and

ğ‘£ğ‘£ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š are maximum and minimum sums of the breadth scores from all genes respectively.
ğ‘£ğ‘£ğ‘–ğ‘– â€² =

ğ‘£ğ‘£ğ‘–ğ‘– âˆ’ ğ‘£ğ‘£ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š
ğ‘£ğ‘£ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š âˆ’ ğ‘£ğ‘£ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š

The association score of gene i with the H3K27me3 domain (ğ‘ğ‘ğ‘–ğ‘– ) was then calculated as the product of the
scaled sum of breadth scores (ğ‘£ğ‘£ğ‘–ğ‘– â€²) and a proportion of cell types where the gene was associated with the

broad H3K27me3 domain. To include genes without any broad H3K27me3 domains in any cell types, we
added a pseudo-count of 1.
ğ‘šğ‘š

ğ‘ğ‘ğ‘–ğ‘– = ğ‘£ğ‘£ğ‘–ğ‘– â€² âˆ™ ï¿½

ğ‘˜ğ‘˜=1

ğ‘‹ğ‘‹ğ‘–ğ‘–,ğ‘˜ğ‘˜ + 1
ğ‘šğ‘š + 1

Finally, we re-scaled the association score into a range of 0 (min) and 1 (max) to obtain the repressive
tendency score (RTS) for the gene. For gene i, RTS is defined as follows, where ğ‘ğ‘ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š and ğ‘ğ‘ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š are

maximum and minimum association scores for all genes, respectively.

ğ‘…ğ‘…ğ‘–ğ‘– =

ğ‘ğ‘ğ‘–ğ‘– âˆ’ ğ‘ğ‘ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š
ğ‘ğ‘ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š âˆ’ ğ‘ğ‘ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š

22

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Performance analysis of TRIAGE against existing methods. We extensively analyzed performance of
TRIAGE against existing computational methods using various metrics. These include metrics based on
(i) breadth of H3K4me3 peaks proximal to the gene1, (ii) breadth of H3K27me3 peaks at the gene locus
multiplied by the corresponding expression level in a spatially heterogenous cell population2 and (iii)
super-enhancer (SE)8,24 as well as common practices of differentially expressed gene (DEG) analysis.

a. H3K4me3 breadth
Benayoun et al. postulated that broad deposition of H3K4me3 proximal to the gene is an indicator of cell
identity gene by ensuring transcriptional consistency1. As a HM of the gene activation, the study
demonstrated efficacy of breadth of H3K4me3 peaks as a single determinant to identify cell identity
genes across different tissue and cell types. A major limitation of this approach is requirement of input
H3K4me3 ChIP-seq data, which can be especially problematic at the single-cell resolution55. TRIAGE
requires no input ChIP-seq data as it effectively utilizes epigenetic information collected from more than
100 diverse tissue and cell types represented by the Roadmap project14.

To compare performance of TRIAGE against the H3K4me3 breadth-based metric, we used the 5 distinct
tissue groups (See Datasets). H3K4me3 peaks were assigned to nearest RefSeq genes using an in-house
Python script. Peaks located further than 2.5kb from any RefSeq TSSs were excluded. For genes with
multiple assigned peaks, the broadest H3K4me3 peak was used to annotate the gene. Subsequently, genes
were ranked by the breadth of the H3K4me3 peak.

b. Functional heterogeneity (FH) score
Previously, Rehimi et al. conceptualized that a broad H3K27me3 domain is often associated with
regulatory genes to spatially restrict their expression in developing chicken embryo2. This observation led
to a metric, called FH score, which integrates information from the gene expression and a breadth of
H3K27me3 at the gene locus in a given cell state. While TRIAGE uses a similar quantification, the RTS
23

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

captures a much more generalizable metric by interrogating H3K27me3 depositions from diverse tissue
and cell types. This renders TRIAGE as a broadly applicable method to any tissue or cell states, without
requiring input H3K27me3 data.

To test performance of TRIAGE on predicting developmental regulators against FH score, we used
chicken embryo dataset for enriched H3K27me3 domains identified in Rehimiâ€™s study and the gene
expression data (GSE89606)2. These datasets satisfy the assumption of spatially heterogenous gene
expression to calculate the FH score. We also downloaded genome annotation file (GFF3 format) for
galGal4 chicken genome assembly (https://asia.ensembl.org/info/data/ftp/index.html) to quantify breadth
of H3K27me3 peaks at the gene using BEDTOOLS intersect program56. Furthermore, while the
assumption of spatially heterogeneous gene expression is not strictly met, we also included FH score to
evaluate its performance and applicability on the selected 5 distinct tissue groups (See Datasets).

Genes were ranked at both developmental time-points (HH14 and HH19) based on 3 metrics; (i)
normalized gene expression value (TPM), (ii) FH score from Rehimiâ€™s study, and (iii) DS from TRIAGE.
A total of 13,214 genes with an expression value (TPM>0) were included. We analyzed enrichment of 19
related GO BP terms used in Rehimiâ€™s study using Fisherâ€™s exact test (one-tailed) (Supplementary Fig.
4d).

c. Super-enhancer (SE) based approach
Super-enhancers are defined as a cluster of enhancers characterized by exceptionally high level of
Mediator signal or enhancer-associated HMs such as H3K27ac8,12,57,58. SEs have been studied as a
genomic hot-spot to understand causal determinant of cell type-specific transcriptions in development and
disease57,58. While accurately assigning target genes to SEs is not trivial, we aimed to test efficacy of
TRIAGE to capture cell type-specific regulatory information compared to a simple but commonly used
SE-based approach.
24

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

One way to functionally annotate genomic regions is by associating with the nearest gene (e.g.
GREAT)59. We downloaded lists of SEs for 5 selected tissue-types from a published SE database SEdb
(http://www.licpathway.net/sedb/index.php)24; (i) Heart left ventricle, (ii) Lung_30y, (iii) Pancreas, (iv)
Psoas muscle_30y, and (v) Brain astrocyte which were linked to Roadmap epigenomes E095 (Left
ventricle), E096 (Lung), E098 (Pancreas), E100 (Psoas muscle) and ENCODE astrocyte (Brain)
respectively. The algorithm to define SEs, ROSE (Rank-Order of Super-Enhancers) gives a binary
outcome (i.e. SE or not) for each enhancer element8. As such, we extracted all nearest active genes of SEs
and compared their functional enrichment against the same number of highly ranked genes by TRIAGE
(Left ventricle (n=557), Lung (n=955), Pancreas (n=382), Psoas muscle (n=409) and Astrocyte (n=689))
using Fisherâ€™s exact test (one-tailed).

d. Differentially expressed gene (DEG) analysis
DEG analysis is a commonly used method to identify cell type-specific genes by comparing expression
values of genes between biologically different conditions (e.g. diseased vs. healthy tissues). Due to its
comparative nature, success of the DEG analysis is highly dependent on careful selection of the control
set. On the other hand, TRIAGE requires neither any prior knowledge on the reference point nor an
arbitrary statistical threshold. We aimed to test performance of TRIAGE to identify genes governing cell
fate against various approaches of the DEG analysis. To this end, we used published single-cell
transcriptomes for in vitro cardiac-directed differentiation26 as well as selected bulk RNA-seq data for 3
distinct tissue groups (i.e. Blood, Brain and Heart) from the Roadmap project14.

We obtained cardiac single-cell transcriptomes for differentiation days 2 and 30 from the ArrayExpress
database (E-MTAB-6268). The data were processed and cells were clustered as previously described26.
For the Roadmap data, we extracted RNA-seq data for 3 representative samples for each tissue group
(Blood; E037, E038, E047, Brain; E070, E071, E082 and Heart; E095, E104, E105). We calculated mean
25

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

expression values of genes within each group or cell cluster. Subsequently, genes were ranked by fold
change (FC) of the average expression value between different groups or clusters. We also tested
performance of TRIAGE against DEG analysis with the input gene set restricted to only TFs. To this end,
we first excluded all non-TF genes from the input data. While DEG analysis often focuses on
differentially expressed TFs as a candidate regulatory gene set, TRIAGE offers an unsupervised approach
to prioritize cell type-specific regulatory genes, without requiring any prior knowledge on the gene set.

e. H3K27me3 gain/loss function
Gain or loss of H3K27me3 dynamically regulates transcription of developmental genes in a cell typespecific fashion10,11. Therefore, any noticeable difference in the H3K27me3 deposition between distinct
temporal points would indicate transcriptional change of the gene. Here we tested how TRIAGE performs
against a simple gain/loss H3K27me3 function using a published dataset for induced in vitro differentiation
of human cardiovascular cells between two different time-points; before differentiation (day0) and
definitive cardiovascular cell stage (day14)3.

To this end, we first obtained AffyExon microarray expression (GSE19090) and H3K27me3 ChIP-seq
(GSE35583) data. We averaged probeset values to obtain the gene expression value and merged H3K27me3
peaks from replicates. To quantify H3K27me3 depositions, we mapped peaks to regions spanning from
2.5kb upstream of RefSeq TSSs to the entire gene body, which is represented by the number of overlapped
base-pairs. We normalized depositions by the size of the region to get a value ranging between 0 (complete
absence of H3K27me3) and 1 (completely covered by H3K27me3). Finally, change in the H3K27me3
deposition between the two time-points was calculated for all genes (i.e. âˆ†ğ»ğ»3ğ¾ğ¾27ğ‘šğ‘šğ‘šğ‘š3 =

ğ»ğ»3ğ¾ğ¾27ğ‘šğ‘šğ‘šğ‘š3ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘14 âˆ’ ğ»ğ»3ğ¾ğ¾27ğ‘šğ‘šğ‘šğ‘š3ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘0 ). We ranked genes by loss of the H3K27me3 signal, DS and the
expression values at day14.

26

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Statistical properties of the DS. We defined a statistical test to gauge if a DS assigned to a gene is
higher than expected. The expected DS of a gene is based on two components: the expected RTS given
the observed level of expression, and the expected level of expression given the observed RTS of the
gene. The test first estimates p-values for the two test statistics, which are then combined by Fisherâ€™s
method to yield a single p-value based on the chi-squared distribution. In practical terms, an empirical
null distribution is generated from repeated, random permutation of each test statistic of n comparable
genes. Comparable genes are defined as those with the closest value to the gene of interest, in terms of the
parameter that is not the test statistic (i.e. expression level or RTS). The p-value is then the probability
that the rank of the gene of interest improves as a result of the random permutation.

Functional enrichment analysis. To compare efficacy of TRIAGE against other existing methods in
prioritizing genes functionally important to a given tissue or cell state, we used a simple systematic
approach to analyze enrichment of a selected GO term. For annotation purposes, we ranked only proteincoding genes. Ranked genes by a given metric (e.g. DS, gene expression value etc.) were first binned

into a percentile bin (i.e. each bin includes 1% of the total gene populations in a given dataset). At
each rank bin, we quantified enrichment of a selected GO term using Fisherâ€™s exact test (onetailed). Essentially, we tested how significantly the GO term was enriched among genes above a
rank bin ğ‘¥ğ‘¥ (i.e. above top ğ‘¥ğ‘¥% of the gene population) compared to the rest using a sliding window.
The resultant significance (âˆ’ğ‘™ğ‘™ğ‘™ğ‘™ğ‘™ğ‘™10 ğ‘ğ‘) was plotted against the rank bin, allowing visualization of

how the enrichment changes as more lowly ranked genes were included in the analysis.

Consistency of the RTS between different peak callers. To assess how the RTS changes with different
peak calling methods, we independently calculated the RTS using peaks identified by 3 different peak
callers, namely MACS2, SPP and Homer60-62. Briefly, we first downloaded mapped ChIP-seq reads in
tagAlign format for the 111 Roadmap cell types. Peaks were identified by comparing H3K27me3 tag
27

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

signals with the input for each peak caller across the cell types. For MACS2 peak caller, â€˜callpeakâ€™ program
was used with â€˜broadâ€™ and â€˜broad-cutoffâ€™ of 0.1 options to capture broad deposition of H3K27me362. For
SPP peak caller, â€˜get.broad.enrichment.clustersâ€™ function (available under â€˜sppâ€™ R library) with
window.sizes=1000 and z.thr=3 was used as recommended for capturing broad HMs60. For Homer peak
caller, â€˜findPeaksâ€™ program was used with â€˜-style histoneâ€™. This parameter ensures the peak caller to initially
find peaks of size 500 bp and subsequently stitch into regions with 1000bp; a suitable approach to identify
broad regions of histone modifications60. From outputs from each peak caller, we calculated RTS values as
described above. Subsequently, DSs were computed for 3 distinct Roadmap tissue groups; Left ventricle
(E095), Germinal matrix (E070) and T helper naÃ¯ve cells (E038), using these 3 different versions of the
RTS. TFs with a selected GO term (Heart development GO:0007507, Brain development GO:0007420 and
T cell differentiation GO:0030217 respectively) were used as the positive gene set for the enrichment
analysis.

Accuracy of estimated RTSs. We estimated the RTS from 111 human cell types in Roadmap. To
understand the presence of sampling bias, we performed a bootstrapping analysis by randomly re-sampling
cell types 10,000 times. For each re-sampling, we calculated the RTS for each gene. We collected the
empirical bootstrap distribution of RTSs for each gene. Estimated RTSs of all 26,833 genes were within 1
standard deviation of their respective mean, which supports consistency of the estimated RTS.

Saturation of H3K27me3 signals. To understand whether the 111 cell types in Roadmap provide sufficient
data to estimate stable RTSs, we developed an iterative process to quantify stability of the RTS with a
differing number of cell type samples. Suppose we have n number of genes each of which has a RTS
calculated based on H3K27me3 data observed in k number of cell types. We defined saturation state as a
state where any change in the RTS for a given gene as a result of an addition of l number of cell types is
within an arbitrarily defined range.

28

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

If the signal is in the saturation state, adding l number of different cell types would result in insignificant
change to the resultant RTS. To help quantification of the RTS change, we define a term stably ranked
gene. Suppose gene i has an estimated RTS derived from k number of cell types and is ranked at a certain
position (ğ‘¢ğ‘¢ğ‘–ğ‘–,ğ‘˜ğ‘˜ ). We say the gene is stably ranked if a resultant RTS re-calculated with an addition of l

number of cell types put the gene at a rank position (ğ‘¢ğ‘¢ğ‘–ğ‘–,ğ‘˜ğ‘˜+ğ‘™ğ‘™ ) that is within a certain range of rank positions

(ğœƒğœƒ) from the previous rank position (ğ‘¢ğ‘¢ğ‘–ğ‘–,ğ‘˜ğ‘˜ ). In other words, gene i is stably ranked if the resultant RTS change
is not large enough to shift its rank position more than ğœƒğœƒ. Formally, a set of stably ranked genes with an

addition of l number of cell types to k number of cell types (ğºğºğ‘˜ğ‘˜,ğ‘™ğ‘™ ) is a subset of all genes (ğºğºğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ ) and can be
written as the follow.

ğºğºğ‘˜ğ‘˜,ğ‘™ğ‘™ = ï¿½ğ‘–ğ‘– âˆˆ ğºğºğ‘ğ‘ğ‘ğ‘ğ‘ğ‘ | ï¿½ğ‘¢ğ‘¢ğ‘–ğ‘–,ğ‘˜ğ‘˜+ğ‘™ğ‘™ âˆ’ ğ‘¢ğ‘¢ğ‘–ğ‘–,ğ‘˜ğ‘˜ ï¿½ < ğœƒğœƒï¿½
For instance, if gene A is ranked at q position by the RTS calculated using k number of cell types, the gene
A is a stably ranked gene if the rank does not change more than ğœƒğœƒ positions (e.g. 1% of the total gene
number) from q when an additional l number of cell types is included for the subsequent calculation.

We started with k=3 randomly selected cell types and iteratively calculated the proportion of stably ranked
genes at an increment of l=3 randomly selected cell types without replacement until all 111 cell types were
used. To address potential sampling bias, we repeated this process 1,000 times and obtained mean values
and the 95% confidence interval of the estimation (Supplementary Figs. 2a and 2b). We used a range of
different thresholds (i.e. 1~5% of the total gene number) for the stably ranked gene.

Correlation between the expression and the H3K27me3 domain breadth. H3K27me3 represses
transcription of the target gene6 but it is not known whether cell type-specific regulatory genes have a
distinct functional relationship with this repressive HM. Based on strong association of cell type-specific

29

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

TFs with broad H3K27me3 domains, we questioned whether the repressive effect of H3K27me3 was
more prominent among the cell type-specific TFs. To this end, we first identified five classes of genes
(i.e. (i) 634 VETFs to represent cell type-specific regulatory genes, (ii) 7,445 variably expressed non-TFs,
(iii) 18,708 protein-coding genes, (iv) 793 non-VETFs and (v) 3,805 housekeeping genes). For each gene,
we calculated a Pearsonsâ€™s correlation coefficient between the gene expression value and the breadth of
the corresponding H3K27me3 domain across the 46 Roadmap cell types.

Functional relationship between the repressive tendency and gene transcription. To understand how
the RTS is associated with the transcriptional outcome, we first ranked genes in a descending order of the
RTS. We only considered coding genes and assigned them into a bin of 100 genes. For the gene
expression level, an average expression value of the gene set at each rank bin was calculated across the 46
cell types (Fig. 2d). For the expressional specificity, a proportion of cell types where a given gene was
expressed (RPKM>1 or equivalent) out of the 46 cell types was calculated (Fig. 2c). As there were 100
genes in each rank bin, we calculated the average proportion of the 100 genes in each bin.

Comparison of clustering accuracy. We compared clustering accuracy based on expression values and
DSs using the scRNA-seq mixology benchmarking data set28. The data set we used (sc_10x) was
generated on the 10X platform and provided expression values as counts for each of three distinct,
labelled, human lung adenocarcinoma cell lines. We assessed the clustering of this data across three
methods: SC3 (1.10.0), CORE (ascend 0.9.6) and Seurat (2.3.0)63-65. Each of the clustering methods were
used as detailed by their authors in their documentation or tutorials, including any filtering and scaling
steps. In the SC3 clustering, the k parameter (ks) was set to 3, and the remainder of the parameters across
all three algorithms were chosen as specified in their documentation or left at default.
To quantify the performance of the clustering methods, we used the Adjusted Rand Index as calculated by
the mclust package (5.4.2) (mclust::adjustedRandIndex)66, comparing the cluster assignment in each

30

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

clustering method to the three cell line labels from the mixology data set. The PCA plots in Figure 3 were
generated using the ascend package (ascend::plotPCA)65

Application of TRIAGE to multi-omics platforms. We hypothesized that TRIAGE would be applicable
to any quantifiable genomic data that reasonably reflects the expression level of genes. To demonstrate
applicability of TRIAGE to various multi-omics platforms, we incorporated single-cell transcriptomes25-27,
FANTOM5 cap analysis of gene expression (CAGE) peaks29, human proteomes30 and Roadmap
H3K36me3 ChIP-seq data sets14.

We applied TRIAGE to tabula muris mouse single-cell RNA-seq data sets for nearly 100,000 cells from
20 different tissue types27. We averaged expression values of genes for each tissue type to calculate
corresponding DSs. We also utilized the MOCA data set representing approximately 1.3 million mouse
single-cell transcriptomes capturing a broad spectrum of organ development or organogenesis25. For each
transcriptome sample, we first ranked genes using either the expression value or the DS. We then
analyzed enrichment of VETFs across rank positions. We identified the best p-value (i.e. the lowest pvalue) and the corresponding rank position for each sample.

For the CAGE data set, we used the normalized CAGE tag density for the expression value of the
corresponding gene. The highest CAGE tag density assigned to the gene was used so that each gene was
annotated with a value from a TSS with the highest value. We selected 329 FANTOM5 samples that
covers 25 distinct cell types without a disease annotation (Supplementary Table 1). For each sample, we
applied TRIAGE to calculate the DS of genes. Genes were then ranked by either the expression value or
the DS and the enrichment of VETFs was analyzed at each rank position using Fisherâ€™s exact test. Peak
significance value (defined as the highest -log10p value) and the corresponding rank position were
identified for each sample.

31

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

The human proteomic data provides expression levels of genes, peptides and proteins across 30 different
tissue groups. We used the protein expression value to link to the corresponding gene for the
quantification. Again, TRIAGE was applied to the expression data to convert them into the DS. We
identified peak significance value and the corresponding rank position for each tissue group.

For H3K36me3 data set, we collected mapped reads for H3K36me3 ChIP-seq for the 111 Roadmap cell
types. Earlier findings showed that the gene expression is positively correlated with the H3K36me3 tag
density over the transcribed gene body regions6. For each cell type, we quantified the read density for
each gene by calculating the number of reads per base-pair mapped to the RefSeq gene body. We then
used the tag density as a proxy for the transcriptional abundance of the gene to calculate the DS.

Visualization of multi-omics datasets. To visualize performance of TRIAGE on multiple samples on a
single plot simultaneously, we summarized the performance for each sample by (i) the most significant pvalue (y-axis, Fisherâ€™s exact test for enrichment of VETFs, one-sided) and (ii) the corresponding rank
position where (i) is observed (x-axis, rank ranging from 1 the highest to 100 the lowest). Each sample
was represented as a single point on the plot.

Inter-species application of the TRIAGE. The RTS for the gene was derived from evidence of the
association with H3K27me3 domains across the 111 Roadmap human cell types. Given a high level of
evolutionary conservation for the PRC246, we hypothesized that the RTS calculated from the human data
could be effectively applied to equivalent genes of other species. To test this, we first downloaded a range
of transcriptomic data sets from different species covering the 5 selected tissue-groups (Supplementary
Table 1). We then performed inter-species gene mapping using online Ensembl bioMart
(http://asia.ensembl.org/biomart/martview/) by identifying human orthologues67. Only genes mappable to
human equivalent genes were included in the analysis.

32

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Melanoma gene set enrichment. We used published pre-processed single cell RNA-seq data from
melanoma tumors31.1,252 melanoma cells were isolated from the set of approximately 4,000 cells based
on the authors annotations. Melanoma proliferative and invasive gene sets were obtained from the same
source. Based on the ratio of the average gene expression of the proliferative to invasive genes; the top 50
most proliferative and the top 50 most invasive cells were identified. TRIAGE was applied to the
melanoma gene expression profiles to produce DS profiles. Averages of both expression and the
discordance profiles of the top 50 proliferative and invasive cells were taken. Genes were subsequently
ranked by the expression and discordance values for these representative profiles. For the ranked genes,
fishers exact test was iteratively performed from the top ranked genes down the list as described above;
adding 1% of the genes at each iteration. Gene sets tested for enrichment were obtained from published
melanoma data sets31. False discovery rate was used to correct for multiple hypothesis testing.

Melanoma regulator prediction. The ratio of the mean expression of the proliferative to invasive genes
was used to order the melanoma gene expression profiles. For each of the melanoma single cell gene
expression profiles, TRIAGE was applied to rank the genes according to their DS. Genes were identified
which appeared in the top 50 of the ranked gene expression profiles at least 30 times. For each melanoma
state, genes were ranked by frequency of appearing in the top 50 (Supplementary Table 6). A modified
gene set enrichment analysis was performed to determine if a given gene appearing within the top 50 of
the expression profiles was enriched toward either end of the proliferative to invasive ordering. The
enrichment score was calculated going from proliferative to invasive cells. The score was incremented
when a given gene appeared in the top 50 of the ranked genes, and decremented otherwise, as per the
weighting scheme described previously68. The largest absolute deviation from 0 was the final enrichment
score. To determine the significance of the score 1,000 permutations of randomly ordering the expression
profiles and re-calculating the enrichment score was used as the background. Bonferroni correction was
used to correct for multiple hypothesis testing. For comparison, equivalent analyses were run for genes
ranked according to absolute expression.
33

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Heart Failure pathogenesis dataset. To determine the utility of TRIAGE in identifying regulatory
elements and processes of disease in heart failure pathogenesis we used published pre-processed bulk
RNA-seq data from adult mouse ventricles (GSE58453 and GSE68509)37. Briefly, heart failure was
induced using transverse aortic constriction (TAC) and the small molecule pan-BET inhibitor JQ1 was
used to treat the TAC condition. TRIAGE was applied to the gene set of each condition (SHAM, TAC,
TAC+JQ1) to produce DS profiles. Genes were subsequently ranked by the expression and discordance
values for these representative profiles. For the ranked genes, Fishers exact test was iteratively performed
from the top ranked genes down the list for GO terms of interest.

Gene Ontology Visualization. Gene ontology analysis was performed using DAVID with significance
threshold set at FDR<0.05. The p-values from gene ontology analysis were visualized with the radius of
the circle proportional to the negative natural log of the input p-value.

iTranscriptome Sample Preparation and Data Analysis. Samples were generated according to the
methodology previously published41. E5.5, E6.0, E6.5, E7.0 and E7.5 embryos were cryo-sectioned along
the proximal-distal axis. Populations of approximately 20 cells were collected from different regions of
the cross-section by laser microdissection and processed for RNA sequencing (see Supplementary Fig.
5f). From the RNA-sequencing dataset, differentially expressed genes (DEGs) were screened first by
unsupervised hierarchical clustering method to group samples in the respective regions. Genes with an
expression level FPKM>1 and a variance in transcript level across all samples greater than 0.05 were
selected. To identify inter-region specific DEGs, each of these selected genes was submitted to a t-test
against the level of expression in the other regions. Genes with a p-value<0.01 and a fold change>2.0 or
<0.5 were defined as DEGs. The gene expression pattern (region and level of expression by transcript
reads) of the gene of interest was mapped on the corn plots, where each kernel represents the cell

34

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

population sampled at a defined position in the tissue layers of the embryo, to generate a digital 2D
rendition of the expression domain that emulated the display of the result of whole mount in situ
hybridization.

Generation and Maintenance of Human ESC/iPSC Lines. All human pluripotent stem cell studies
were carried out in accordance with consent from the University of Queenslandâ€™s Institutional Human
Research Ethics approval (HREC#: 2015001434). WTC CRISPRi GCaMP hiPSCs (Karyotype: 46, XY;
RRID CVCL_VM38) were generated using a previously described protocol69 and were generously
provided by M. Mandegar and B. Conklin (UCSF, Gladstone Institute). WTC CRISPRi SIX3-g2 hiPSCs
were generated in this study (see below). All cells were maintained as previously described70. Briefly,
cells were maintained in mTeSR media with supplement (Stem Cell Technologies, Cat.#05850) at 37Âº C
with 5% CO2. WTC CRISPRi GCaMP and WTC CRISPRi SIX3-g2 hiPSC lines were maintained on
Vitronectin XF (Stem Cell Technologies, Cat.#07180) coated plates.

WTC CRISPRi SIX3-g2 hiPSCs. 3 separate guide RNAs (gRNA) targeting the CAGE-defined
transcriptional start sites of the human SIX3 sequence were designed and cloned into the pQM-u6gCNKB doxycycline-inducible construct and transfected into WTC CRISPRi GCaMP hiPSCs using
GeneJuice Transfection Reagent (Merck, Cat.#70967). Stable clones were selected using successive
rounds of re-plating with blasticidine at 10Âµg/ml (Sigma, Cat.#15205). Populations were tested for
knockdown efficiency by qPCR following doxycycline addition at 1 Âµg/ml (Sigma, Cat.#D9891)
continuously from day 0 of cardiac-directed differentiation. WTC CRISPRi SIX3-g2 line displayed high
knockdown efficiency and therefore was chosen.
Guide RNAs designed:

Oligo Sequences

gRNA Name

5â€™ â€“ Forward Primer â€“ 3â€™
5â€™ â€“ Reverse Primer â€“ 3â€™

35

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

SIX3 gRNA1

SIX3 gRNA2

SIX3 gRNA3

F 5â€™ TTGGGCTGAATCTTGACTCGGCGG 3â€™
R 5â€™ AAACCCGCCGAGTCAAGATTCAGC 3â€™
F: 5' TTGGTGTCATTAGGGCGATTGCGG 3'
R: 5' AAACCCGCAATCGCCCTAATGACA 3'
F 5â€™ TTGGCTCTATGTGGCTGGCGGGTG 3â€™
R 5â€™ AAACCACCCGCCAGCCACATAGAG 3â€™

Cell Culture. All human pluripotent stem cell studies were carried out in accordance with consent from
the University of Queenslandâ€™s Institutional Human Research Ethics approval (HREC#: 2015001434).
hiPSCs were maintained in mTeSR media (Stem Cell Technologies, Cat.#05850). Unless otherwise
specified, cardiomyocyte directed differentiation using a monolayer platform was performed with a
modified protocol based on previous reports71. On day -1 of differentiation, hPSCs were dissociated using
0.5% EDTA, plated into vitronectin coated plates at a density of 1.8 x 105 cells/cm2, and cultured
overnight in mTeSR media. Differentiation was induced on day 0 by first washing with PBS, then
changing the culture media to RPMI (ThermoFisher, Cat.#11875119) containing 3ÂµM CHIR99021 (Stem
Cell Technologies, Cat.#72054), 500Âµg/mL BSA (Sigma Aldrich, Cat.#A9418), and 213Âµg/mL ascorbic
acid (Sigma Aldrich, Cat.#A8960). After 3 days of culture, the media was replaced with RPMI containing
500Âµg/mL BSA, 213Âµg/mL ascorbic acid, and 5ÂµM Xav-939 (Stem Cell Technologies, Cat.#72674). On
day 5, the media was exchanged for RPMI containing 500Âµg/mL BSA, and 213Âµg/mL ascorbic acid
without supplemental cytokines. From day 7 onwards, the cultures were fed every 2 days with RPMI plus
1x B27 supplement plus insulin (Life Technologies Australia, Cat.#17504001).

Human melanoma cell lines A2058, MM96L and HT144 were cultured in RPMI 1640 media (InvitrogenLife Technologies) supplemented with 5% foetal bovine serum, 2mM L-glutamine, and 5 mg/ml
penicillin/streptomycin. Cells under glutamine deprivation were grown in RPMI 1640 media without

36

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

supplementation of L-glutamine while cells under glucose deprivation were grown in RPMI 1640 glucosefree media supplemented as described above.

Quantitative RT-PCR. For quantitative RT-PCR, total RNA was isolated using the RNeasy Mini kit
(Qiagen, Cat.#74106). First-strand cDNA synthesis was generated using the Superscript III First Strand
Synthesis System (ThermoFisher, Cat.#18080051). Quantitative RT-PCR was performed using SYBR
Green PCR Master Mix (ThermoFisher, Cat.#4312704) on a ViiA 7 Real-Time PCR System (Applied
Biosystems). The copy number for each transcript is expressed relative to that of housekeeping gene
HPRT1. Samples were run in biological triplicate. FC was calculated on a gene by gene basis as gene
expression divided by control gene expression. The following are qRT-PCR primers utilized in this study:

Gene Name

5â€™-Forward Primer-3â€™

5â€™-Reverse Primer-3â€™

HPRT

TGACACTGGCAAAACAATGCA

GGTCCTTTTCACCAGCAAGCT

SIX3

GCAGAAGACGCATTGCTTCAA

CCCAGCAAGAAACGCGAAC

SOX2

TGGACAGTTACGCGCACAT

CGAGTAGGACATGCTGTAGGT

HHEX

AATGCTGGATGATGACCACT

TAATTGAGCAGTGCACCAAA

GATA6

TGCAATGCTTGTGGACTCTA

GTGGGGGAAGTATTTTTGCT

SOX17

ACGCCGAGTTGAGCAAGA

TCTGCCTCCTCCACGAAG

FOXA2

TGCACTCGGCTTCCAGTATG

CATGTTGCTCACGGAGGAGT

NODAL

TGGAGGTGGGATGAAGTCACCTAT

AACCCAGCCTGAGGCAATGAGATT

GSC

GAGGAGAAAGTGGAGGTCTGGTT

CTCTGATGAGGACCGCTTCTG

CACATTGTAGTGGGCAGTGG

CGCCACCAAACTGAGATGAT

EOMES

37

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

TGACAACTTGTTGCCAACTCCCTG

TTCAGCAGTGGAGGAAGAGCAGAA

GATA4

GACCTGGGACTTGGAGGATA

ACAGGAGAGATGCAGTGTGC

DKK1

AACAGCTATCCAAATGCAG

TCACAGGGGAGTTCCATAAA

MEST

CTGTGGGTGTGGTTGGAAGT

TGTCACTGAAGCCAAAGCCT

T (Bry)

GTCAGAATAGGTTGGAGAATTG

CAAATCCTCATCCTCAGTTTG

MESP1

TCGAAGTGGTTCCTTGGCAGAC

CCTCCTGCTTGCCTCAAAGTGTC

WNT8A

GCAGAGGCGGAACTGATCTT

CGACCCTCTGTGCCATAGATG

WNT3A

AACTACGTGGAGATCATGCCC

GACTCCCTGGTAGCTTTGTC

SOX7

RNA was extracted from melanoma cells using Trizol extraction (Sigma Aldrich) and first-strand cDNA
prepared by reverse transcription using using iSCRIPT RT Supermix (Bio-rad). Gene expression was
quantified using SYBR Green or Taqman mastermixes (Applied Biosystems) on a ViiA7 real time cycler
(Applied Biosystems). SYBR based qRT-PCR primers used in the study were Î²-2-microglobulin (Fwd
5â€™CATTCGG5â€™GCCGAGATGTCT, Rev 5â€™CTCCAGGCCAGAAAGAGAGAGTAG), TFAP2C (Fwd 5â€™
CTGTTGCTGCACGATCAGACA; Rev 5â€™ CTCAGTGGGGTTCATTACGGC) and AXL (Fwd 5â€™
TTTCCTGAGTGAAGCGGTCT; Rev 5â€™ TCGTTCAGAACCCTGGAAAC). Taqman primers were Î²-2microglobulin (Hs00187842_m1) and MITF (Hs01117294_m1) (Applied Biosystems). Comparative CT
analysis was used to determine relative mRNA expression relative to the Î²-2-microglobulin housekeeping
control gene. Relative expression data for each gene between the 0hr and 36/48 hour time points was
transformed to z-scores and used to generate heat maps.

Cloning and lentivirus production. The open reading frame of the human TFAP2C gene was cloned
into the pLVX-Tight-puro construct (Clonetech) and used to generate Lentivirus using the Lenti-X HT
packaging system (Clontech) according to the manufacturer's protocol. Melanoma cell lines were
transduced and selected in puromycin as described previously72.
38

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Flow Cytometry. On day 2 of cardiac differentiation cells were dissociated using 0.5% EDTA and put
into blocking buffer of 50% fetal bovine serum (FBS) in Dulbeccoâ€™s Modified Eagle Medium
(DMEM)/F12 (ThermoFisher, Cat.#11320033). Cells were then pelleted and resuspended in 10% FBS in
DMEM media. Cells were labeled live for flow cytometry using CD184 (Becton Dickinson,
Cat.#555974), EpCAM (Becton Dickinson, Cat.#347199) and corresponding isotype controls were used
to gate the cells. On day 15 of cardiac differentiation cells were fixed with 4% paraformaldehyde (Sigma,
Cat.#158127) and permeabilized in 0.75% saponin (Sigma, Cat.#S7900). On day 15 of cardiac
differentiation fixed cells were labeled for flow cytometry using alpha-actinin (Miltenyi Biotec,
Cat.#130106937) and corresponding isotype control. Cells were analyzed using a BD FACSCANTO II
(Becton Dickinson, San Jose, CA) with FACSDiva software (BD Biosciences). Data analysis was
performed using FlowJo (Tree Star, Ashland, Oregon).

Ciona robusta CRISPR/Cas9 gene editing For Rnf220 (KH2012:KH.C8.791) loss of function, 3
sgRNAs were designed to avoid genomic off-targets and tested as described73. sgRNA expressing
cassettes (U6 > sgRNA) were assembled by single step overlap PCR. Individual PCR products (~25 Âµg)
were electroporated with EF1a > NLS::Cas9::NLS (20 Âµg), Myod905 > Venus (50 Âµg), driving
ubiquitous expression of Cas9 and a widely expressed fluorescent reporter construct, respectively, as
described74. Efficient electroporation was confirmed by observation of fluorescence before genomic DNA
extraction around 16 hpf (18Â°C) using QIAamp DNA Micro kit (Qiagen, German Town, MD).
Mutagenesis efficacy of individual sgRNAs, as a linear function of Cas9-induced indel frequency, was
estimated from electrophoregrams following Sanger sequencing of the targeted regions amplified from
extracted genomic DNA by PCR. Results of the relative quantification of the indel frequency (â€˜corrected
peakshiftâ€™ of 22% and 16%) for sgRNAs 2 and 3 was considered high enough for both sgRNAs targeting
Rnf220, which were finally selected. The corresponding cassettes were cloned into plasmid for repeated

39

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

electroporations to study the loss of function of Rnf220. In order to control the specificity of the
CRISPR/Cas9 system, sgRNAs targeting Tyrosinase, a gene not expressed in the cardiopharyngeal
lineage, was electroporated in parallel. For imaging experiments, sgRNAs (25 Âµg) were electroporated
with Mesp > NLS::Cas9::NLS (20 Âµg), Mesp > H2B:GFP (50 Âµg) and Mesp > mCherry (50 Âµg) .
Sequences of the DNA targets and oligonucleotides used for the sgRNAs:

sgRNA name

Universal sgRNA name Protospacer + PAM Sequence

Doench 16' score

RNF220_sg1

RNF220_p.A

GCGATGAACGGATGCGCTGG CGG

64

RNF220_sg2

RNF220.e1.A

GGGTCGGGTTGATTGCACTT GGG

63

RNF220_sg3

RNF220.e1.B

CCCCCACCAGACTTCAGCAG CGG

65

TyrC

sgTYR_e5.B

TCGATACTACCTGCTTAAGT GGG

54

sgRNA name

OSO Primer Forward

RNF220_sg1

gCGATGAACGGATGCGCTGGgtttaagagctatgctggaaacag

RNF220_sg2

gGGTCGGGTTGATTGCACTTgtttaagagctatgctggaaacag

RNF220_sg3

gCCCCACCAGACTTCAGCAGgtttaagagctatgctggaaacag

TyrC

gCGATACTACCTGCTTAAGTgtttaagagctatgctggaaacag

OSO Primer Reverse
RNF220_sg1

CCAGCGCATCCGTTCATCGcatctataccatcggatgccttc

RNF220_sg2

AAGTGCAATCAACCCGACCcatctataccatcggatgccttc

RNF220_sg3

CTGCTGAAGTCTGGTGGGGcatctataccatcggatgccttc

TyrC

ACTTAAGCAGGTAGTATCGcatctataccatcggatgccttc

40

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Embryos were fixed in 4% MEM-FA for 30 minutes, incubated with an NH4Cl solution, and imaged
using Leica SP8 X Confocal microscope.

Data availability. The source data underlying Figs 1,2,3 and 6 and Supplementary Fig. 2 are provided as
a source data file. All relevant data are available from the authors upon request.

Code availability. We provide the source code written in Python and R
(https://github.com/woojunshim/TRIAGE). Users can also run the TRIAGE analysis using a web
accessible interface (http://bioinf.scmb.uq.edu.au/adhoc/).

Quantification and statistical analysis. Unless otherwise noted, all data are represented as mean Â±
standard error of mean (SEM). Indicated sample sizes (n) represent biological replicates including
independent cell culture replicates and individual tissue samples. No methods were used to determine
whether data met assumptions of the statistical approach or not. Due to the nature of the experiments,
randomization was not performed and the investigators were not blinded. Statistical significance was
determined in GraphPad Prism 7 software by using studentâ€™s t test (unpaired, two-tailed) or ordinary oneway ANOVA unless otherwise noted. Results were considered to be significant at p < 0.01(*). Statistical
parameters are reported in the respective figures and figure legends. All statistical data are represented as
mean Â± SEM.

ACKNOWLEDGEMENTS
E.S acknowledges funding by Childrenâ€™s Hospital Foundation Queensland (Award Reference Number:
50268). B.V. acknowledges funding by American Heart Association grant #18PRE33990254. The Ciona
work was supported by NIH/NHLBI award R01 HL108643 to L.C. M.A. was supported by the Swiss
National Science Foundation (project P2LAP3_178056), P.P.L.T. is supported by the National Health and
41

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Medical Research Council of Australia (Grant 1110751). N.P is supported by the National Health and
Medical Research Council of Australia (Grant APP1143163) and the Australian Research Council (Grant
SR1101002).

AUTHOR CONTRIBUTIONS
WJS: Developed the computational basis for the study, performed data analysis and wrote the manuscript
ES: Contributed to experimental and computational design for the study, performed data analysis, carried
out functional genetic studies in hPSCs and wrote the manuscript
JX: Assisted with computational analysis and developed web interactive interface
MA: Performed computational analysis on HF pathogenesis data
GA: Performed computational analysis on HF pathogenesis data
SS: Assisted the computational analysis on different single-cell data platforms
BB: Performed computational analysis on melanoma studies
YS: Performed computational analysis on Mouse Organogenesis Cell Atlas data
BV: Performed functional analysis on ciona and validated the findings
GP: Assisted with spatiotemporal transcriptomic profiling of mouse gastrulation
NJ: Assisted with spatiotemporal transcriptomic profiling of mouse gastrulation
YW: Helped with computational analysis of epigenetic data
MP: Assisted with analysis and interpretation of melanoma data
AS: Carried out experiments involving melanoma analysis
YC: Carried out experiments involving melanoma analysis
PT: Supervised work on spatiotemporal transcriptomic profiling of mouse gastrulation
LC: Performed functional analysis on ciona and validated the findings
QN: Provided assistance to implement TRIAGE on single-cell data sets
MB and NJP: Supervised the project, raised funding, and wrote the manuscript
42

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

DECLARATION OF INTERESTS
The authors declare no competing interests.

43

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

FIGURES

44

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Fig. 1: Broad H3K27me3 domains are associated with cell type-specific regulatory genes.
(a) Broad HM domains identify a set of common genes. For each HM type, genes are ranked by the
breadth of the associated HM domain across 111 Roadmap cell types and grouped into bins of 100 genes
(x-axis). Mean similarity between cell types of the same rank bin is shown (y-axis). (Inset) Top 100 genes
(i.e. first rank bin) are significantly more similar (p<2.2e-16 for all HMs, Wilcoxon rank-sum test, onetailed) than genes with narrower domains. Scale bars show the 95% confidence interval. Source data are
provided as a Source Data file.
(b) Enrichment of tissue-type-specific gene ontology (GO) biological process (BP) terms associated with
most highly expressed 50 VETFs in 5 different cell types (Fisherâ€™s exact test, one-tailed); Brain germinal
matrix (E070), Pancreatic islets (E087), Left ventricle (E095), Primary T helper naÃ¯ve cells (E038) and
H1 BMP4-derived mesendoderm (E004).
(c) VETFs are strongly associated with broad H3K27me3 domains. Genes are ranked by the breadth of
the associated HM domain across 111 Roadmap cell types and grouped into percentile bins (x-axis). Mean
enrichment of VETFs for all pair-wise cell types with the 95% confidence interval is shown (y-axis)
(p=6.66e-16 for top 5% broadest H3K27me3 domains, Fisherâ€™s exact test, one-tailed). Source data are
provided as a Source Data file. (Inset) Expression levels of the 634 VETFs (row) across the 46 Roadmap
samples (column).
(d) Functional enrichment of top 200 genes most frequently associated with top 5% broadest HM
domains across the 111 Roadmap cell types (Fisherâ€™s exact test, one-tailed).
(e) Gene expression level (top) and the H3K27me3 breadth (bottom) for cardiac-specific regulatory genes
and structural genes across 18 Roadmap samples; Heart (E095, E104, E105), Brain (E070, E071, E082),
Epithelial (E057, E058, E059), Blood (E037, E038, E047), ES cell (E003, E016, E024) and ES-deriv.
(E004, E005, E006).
(f) HM domains in the proximal region (-2.5kb upstream of the RefSeq TSS to +25kb downstream) of a
cardiac regulatory gene NKX2-5 and a structural gene MYH7, collected from the 111 Roadmap cell types.

45

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Fig. 2: Genes that are frequently associated with broad H3K27me3 domains regulate diverse
developmental and disease processes.
(a) Schematic diagram showing steps involved in calculation of the repressive tendency score (RTS).
(b) (Top) Distribution of RTS values. Red dashed line is the inflection point on the interpolated curve
(RTS=0.03022) above which genes exhibit a substantially higher RTS than the rest (n=1,359, priority
genes). (Bottom) Functional enrichment of gene sets sorted by the RTS (Fisherâ€™s exact test, one-tailed)
(Supplementary Table 4 for the full list).
(c) Expressional specificity of protein-coding genes sorted by the RTS. Each rank bin includes 100 genes.
Average proportion of cell types where the gene is expressed (RPKM>1) is calculated for each rank bin (yaxis). Shades mark the 95% confidence interval. Source data are provided as a Source Data file.

46

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

(d) Gene expression level and the RTS. Each rank bin includes 100 genes. Average expression value for
each bin, with 95% confidence interval (shade) is shown (y-axis). Source data are provided as a Source
Data file.
(e) VETFs are significantly associated with a high RTS (p<2.2e-16 at the first rank position, Fisherâ€™s exact
test, one-tailed). Each rank bin includes 1% of all RefSeq genes with a RTS (n=26,833). Red dashed line
represents a uniform distribution (proportion=0.01)
(f) Genes with a high RTS are enriched with various development and disease processes as well as signaling
pathways (Supplementary Table 4 for the full list). Each rank bin includes 1% of all RefSeq genes with a
RTS (n=26,833). Asterisks mark significant enrichment of a given term among top 10% genes (BenjaminiHochberg FDR<0.05, Fisherâ€™s exact test, one-tailed).

47

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Fig. 3: TRIAGE effectively infers cell type-specific regulatory genes of somatic cell types across
diverse species of the animal kingdom.
(a) TRIAGE transforms readouts of gene expression into discordance score (DS) to prioritize genes with
important regulatory potential.
(b) Breadths of H3K27me3 domains (in base-pairs) associated with selected cell type-specific regulatory,
structural and housekeeping genes.
(c) TRIAGE prioritizes tissue-type-specific regulatory genes. Average expression values (Exp.) from GTEx
samples for each tissue type is transformed into the DS (Dis.).

48

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

(d) TRIAGE shifts distributions of VETFs and housekeeping genes from transcriptomes of the 46 Roadmap
cell types. Each rank bin includes 1% of all expressed genes in a given cell type. VETFs are significantly
associated with a high DS (top 1%) in all cell types (p<2.2e-16 for all cell types, Fisherâ€™s exact test, onetailed) while proportions of housekeeping genes are substantially reduced after the transformation (p<2.2e16 for top 1% genes, Wilcoxon rank-sum test, one-tailed). Scale bars show the 95% confidence interval.
Source data are provided as a Source Data file.
(e) Receiver-operating characteristic (ROC) plots comparing performance of TRIAGE against existing
methods on Roadmap heart (E095) and brain (E070) samples. Area under the curve (AUC) values are
shown on the right bottom corner of the plot. For more extensive performance analysis (including other
tissue types), see Supplementary Fig. 4 and Supplementary Table 7 for comparison between TRIAGE
and SE-based approach.
(f) TRIAGE effectively identifies genes with cell type-specific development functions on left ventricle
(E095) and astrocyte (E125) Roadmap samples, with a greater sensitivity than super-enhancer (SE)-based
approach. Enrichment of a given GO term is compared between (i) n number of genes as the nearest active
gene to SEs and (ii) top n number of genes by the DS (Supplementary Fig. 4b and Supplementary Table
7 for the full table).
(g) Enrichment of TFs annotated with â€˜heart developmentâ€™ term (GO:0007507) in cardiac samples across
different animal species (Fisherâ€™s exact test, one-tailed). Genes are sorted in a descending order by the DS
(red) or the expression value (cyan) and grouped into a percentile bin. Each rank bin includes 1% of all
expressed (RPKM>1 or equivalent) genes in a given sample.
(h) Enrichment of TFs with a tissue-type-specific development GO term among top 100 genes from the
expression value (blue) or the DS (red) across different animal species (Fisherâ€™s exact test, one-sided).
Hyphen (-) indicates no data set available.

49

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Fig. 4: TRIAGE is highly applicable and scalable for multi-omics datasets.
(a) Top 10 genes identified by expression or DS from hiPSC cardiomyocyte single-cell RNA-seq for in
vitro cardiac-directed differentiation of day 3026.
(b) TRIAGE transforms scRNA-seq for in vitro differentiation of cardiomyocytes at day 30 (left) to
reveal known cardiac regulators (right).
(c) TRIAGE-transformation shifts distributions of different functional genes. Enrichment of a gene set
with 1. housekeeping, 2. heart signaling (genes with heart development term GO:0007507 and at least one
KEGG signaling pathway term), 3. sarcomere (genes with sarcomere term GO:0030017) or 4. heart TFs

50

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

(TFs with heart development term GO:0007507) in in vitro differentiated cardiomyocytes at day 30.
Genes are sorted by either the expression value (left) or the DS (right) and grouped into a percentile bin.
Each rank bin includes 1% of all expressed genes in the dataset. Enrichment of a given gene set is
calculated at each rank bin (Fisherâ€™s exact test, one-tailed).
(d) UMAP representation of cell clustering using transcriptomic expression (left) or TRIAGE (right).
(e) Enrichment of developmental GO BP terms primarily associated with stage-specific regulatory
developmental processes during in vitro cardiac-directed differentiation (y-axis) (Fisherâ€™s exact test, onetailed) that are consistently identified by TRIAGE but not original expression. In contrast, expression data
strongly detect structural and housekeeping genes.
(f) Enrichment of developmental GO terms among genes ranked by TRIAGE (red), expression (blue) or
fold-change of gene expression (green or purple) in sub-cell populations (i.e. cluster) from in vitro
cardiac-directed differentiation datasets (days 2 and 30). Each rank bin includes 1% of all genes.
(g,h,j) TRIAGE is applicable to (g) different scRNA-seq sequencing platforms (i.e. Smart-seq2 or
Droplet 10X chromium, (h) the mouse organogenesis cell atlas (MOCA) data as well as (j) various
readouts of the gene expression (i.e. CAGE-seq, proteome and H3K36me3 tag density). Genes are sorted
by either expression value or DS and grouped into a percentile bin. Enrichment of VETFs for each sample
is summarized by the most significant p-value (y-axis) the corresponding rank bin position (x-axis).
(i) Comparison of scRNA-seq cluster assignment efficiency between original expression and TRIAGE
analyzed data using Mixology data sets28.

51

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Fig. 5: Determining the regulatory basis of disease pathogenesis and therapy.
(a) Tables showing the top ranked genes from proliferative melanoma cells or invasive melanoma cells
indicating rank position by original expression (left) or TRIAGE (right). Genes are identified based on
their known roles as structural or regulatory genes in melanoma.
(b) Fisherâ€™s exact test enrichment of positive gene sets for proliferative and invasive melanoma states
demonstrating high specificity of enrichment for cell type-specific gene signatures only with TRIAGE.
(c) Gene set enrichment analysis (GSEA) for ETV5, TFAP2A, TBX3 and TFAP2C. The y-axis
corresponds to the enrichment score with gene expression profiles ranked by TRIAGE. The x-axis shows
cells ranked from proliferative to invasive. The vertical lines indicate when the respective gene was found
in the top 50 of a ranked expression profile.

52

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

(d) qPCR analysis showing changes in expression of MITF, AXL and TFAP2C in A2058 melanoma cells
over 48hours of glucose deprivation (top) and glutamine deprivation (bottom).
(e) z-score based heat maps showing changes in expression of melanoma genes in three individual BRAF
mutant melanoma cell lines over 36-48 hours of glucose starvation.
(f) Top 10 genes ranked by expression (left) or TRIAGE (right) from SHAM, TAC-vehicle and TAC-JQ1
data from bulk RNA-seq of mice subjected to sham surgery (SHAM), transverse aortic constriction
(TAC-vehicle) and TAC treated with JQ1 (TAC-JQ1).
(g) Enrichment of GO terms associated with cardiac biology and heart failure stress response mechanisms
comparing each condition analyzed by TRIAGE or DE analysis (TAC-veh vs TACJQ1). Genes are
ranked by either the expression value or TRIAGE and binned by rank (each bin includes 1% of all genes)
and the enrichment is calculated at each rank position (y-axis, Fisherâ€™s exact test, one-tailed).

53

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

Fig. 6: Predicting novel regulators of heart development.
(a) Top 10 genes ranked by expression value (left) or TRIAGE (right) from day 2 populations (germ layer
specification) of hiPSC cardiac differentiation, highlighting SIX3 as a candidate novel gene identified by
TRIAGE.

54

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

(b) Breadths of H3K27me3 domains (in base-pairs) associated with SIX3 gene across the 111 NIH
Epigenomes data sets.
(c) Analysis of SIX3 expression during hiPSC-cardiac differentiation represented by t-SNE plots (left),
percentage of cells expressing SIX3 (top right) and gene expression level of SIX3 (bottom right) in each
subpopulation on days 0, 2 and 5.
(d) Corn plots showing the spatial domain of SIX3 expression in the germ layers of E5.5-E7.5 mouse
embryos. Positions of the cell populations (â€˜â€˜kernelsâ€™â€™ in the 2D plot of RNA-seq data) in the embryo: the
proximal-distal location in descending numerical order (1 = most distal site) and in the transverse plane of
the germ layers: endoderm, anterior half (EA) and posterior half (EP); mesoderm, anterior half (MA) and
posterior half (MP); epiblast/ectoderm, anterior (A), posterior (P) containing the primitive streak, right
(R)- anterior (R1) and posterior (R2), left (L) â€“ anterior (L1) and posterior (L2).
(e) Schematic overview of SIX3 gene targeting showing position of gRNAs blocking CAGE-defined TSS
to achieve conditional knockdown of SIX3 in iPSCs.
(f) qPCR analysis of SIX3 transcript abundance in control vs SIX3 CRISPRi KD iPSCs. Source data are
provided as a Source Data file.
(g) Schematic of in vitro hiPSC cardiac-directed differentiation protocol.
(h) qPCR analysis showing significant decreases in endoderm and mesendoderm markers and increases in
mesoderm markers, respectively, in SIX3 CRISPRi KD iPSCs compared to control (n=6-14 technical
replicates per condition from 3-6 experiments).
(i-k) Cells were phenotyped on Day 2 of differentiation for endoderm markers by FACs analysis of
EPCAM/CXCR4. (i) Changes in EPCAM+/CXCR4+ cells between control and dox-treated conditions in
SIX3 CRISPRi KD iPSCs and WTC GCaMP CRISPRi iPSCs are shown (n=12-16 technical replicates per
condition from 4-5 experiments). (j) SIX3 CRISPRi KD iPSCs show significant (p<0.001) reduction in
EPCAM+/CXCR4+ cells compared to dox-treated control iPSCs (WTC GCaMP CRISPRi). (k) Raw
FACS plots of EPCAM/CXCR4 analysis. Source data are provided as a Source Data file.

55

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

(l-n) Analysis of cardiomyocytes by FACs for Î±-actinin. (l) Changes in Î±-actinin+ cells between control
and dox-treated conditions in SIX3 CRISPRi KD iPSCs and WTC GCaMP CRISPRi iPSCs are shown
(n=6 technical replicates per condition from 3 experiments). (m) SIX3 CRISPRi KD iPSCs show no
change in Î±-actinin+ cells compared to dox-treated control iPSCs (WTC GCaMP CRISPRi). (n) Raw
FACS plots of a-actinin analysis. Source data are provided as a Source Data file.
(o) Schematic overview of cardiac development in Ciona from 4 to 72 hours post fertilization (hpf) at
18oC. Adapted from75. TVC: trunk ventral cells; STVC: second TVC; FHP: first heart precursor; SHP:
second heart precursor; ASMF: atrial siphon muscle founder cells; iASMP: inner atrial siphon muscle
precursor; oASMP: outer atrial siphon muscle precursor.
(p) Top 10 genes ranked by expression value (left) or DS (right) from populations found during Ciona
heart development in vivo, highlighting RNF220 as a candidate novel gene identified by TRIAGE.
(q) Breadths of H3K27me3 domains (in base-pairs) associated with RNF220 gene across the 111 NIH
Epigenomes data sets.
(r-s) Mosaic plots (r) and images (s) showing ASM precursor phenotypes at 26 hpf labeled with
Mesp>H2B:GFP and Mesp>mCherry in control knockout and RNF220-knockout animals (n=100). pvalue represents the chi-sq test between two experimental conditions. Images in (s) derived from Ciona
robusta cardiopharyngeal mesoderm.

56

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

References
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Benayoun, B. A. et al. H3K4me3 breadth is linked to cell identity and transcriptional consistency.
Cell 158, 673-688, doi:10.1016/j.cell.2014.06.027 (2014).
Rehimi, R. et al. Epigenomics-Based Identification of Major Cell Identity Regulators within
Heterogeneous Cell Populations. Cell Rep 17, 3062-3076, doi:10.1016/j.celrep.2016.11.046
(2016).
Paige, S. L. et al. A temporal chromatin signature in human embryonic stem cells identifies
regulators of cardiac development. Cell 151, 221-232, doi:S0092-8674(12)01058-6 [pii]
10.1016/j.cell.2012.08.027 (2012).
Cahan, P. et al. CellNet: network biology applied to stem cell engineering. Cell 158, 903-915
(2014).
Rackham, O. J. et al. A predictive computational framework for direct reprogramming between
human cell types. Nature genetics 48, 331 (2016).
Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129,
823-837, doi:10.1016/j.cell.2007.05.009 (2007).
Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in
humans. Nature 470, 279 (2011).
Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key
cell identity genes. Cell 153, 307-319 (2013).
Nakamura, R. et al. Large hypomethylated domains serve as strong repressive machinery for key
developmental genes in vertebrates. Development 141, 2568-2580, doi:10.1242/dev.108548
(2014).
Boyer, L. A. et al. Polycomb complexes repress developmental regulators in murine embryonic
stem cells. Nature 441, 349-353, doi:10.1038/nature04733 (2006).
Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineagecommitted cells. Nature 448, 553-560, doi:10.1038/nature06008 (2007).
Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts
developmental state. Proc Natl Acad Sci U S A 107, 21931-21936, doi:10.1073/pnas.1016071107
(2010).
Palpant, N. J. et al. Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells
Identifies HOPX as a Regulator of Primitive Hematopoiesis. Cell Rep 20, 1597-1608,
doi:10.1016/j.celrep.2017.07.067 (2017).
Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330,
doi:10.1038/nature14248 (2015).
Perez-Lluch, S. et al. Absence of canonical marks of active chromatin in developmentally regulated
genes. Nat Genet 47, 1158-1167, doi:10.1038/ng.3381 (2015).
Schug, J. et al. Promoter features related to tissue specificity as measured by Shannon entropy.
Genome Biol 6, R33, doi:10.1186/gb-2005-6-4-r33 (2005).
Eisenberg, E. & Levanon, E. Y. Human housekeeping genes, revisited. Trends Genet 29, 569-574,
doi:10.1016/j.tig.2013.05.010 (2013).
Lee, T. I. et al. Control of developmental regulators by Polycomb in human embryonic stem cells.
Cell 125, 301-313, doi:10.1016/j.cell.2006.02.043 (2006).
Zhong, Y. F. & Holland, P. W. HomeoDB2: functional expansion of a comparative homeobox gene
database for evolutionary developmental biology. Evol Dev 13, 567-568, doi:10.1111/j.1525142X.2011.00513.x (2011).
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28,
27-30, doi:10.1093/nar/28.1.27 (2000).

57

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

Grote, P. & Herrmann, B. G. The long non-coding RNA Fendrr links epigenetic control mechanisms
to gene regulatory networks in mammalian embryogenesis. RNA Biol 10, 1579-1585,
doi:10.4161/rna.26165 (2013).
Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci
by noncoding RNAs. Cell 129, 1311-1323, doi:10.1016/j.cell.2007.05.022 (2007).
Scornavacca, C., Zickmann, F. & Huson, D. H. Tanglegrams for rooted phylogenetic trees and
networks. Bioinformatics 27, i248-256, doi:10.1093/bioinformatics/btr210 (2011).
Jiang, Y. et al. SEdb: a comprehensive human super-enhancer database. Nucleic Acids Res 47,
D235-D243, doi:10.1093/nar/gky1025 (2019).
Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566,
496-502, doi:10.1038/s41586-019-0969-x (2019).
Friedman, C. E. et al. Single-cell transcriptomic analysis of cardiac differentiation from human PSCs
reveals HOPX-dependent cardiomyocyte maturation. Cell stem cell 23, 586-598. e588 (2018).
Schaum, N. et al. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature
562, 367-372, doi:10.1038/s41586-018-0590-4 (2018).
Tian, L. et al. Benchmarking single cell RNA-sequencing analysis pipelines using mixture control
experiments. Nat Methods 16, 479-487, doi:10.1038/s41592-019-0425-8 (2019).
Forrest, A. R. et al. A promoter-level mammalian expression atlas. Nature 507, 462-470,
doi:10.1038/nature13182 (2014).
Kim, M. S. et al. A draft map of the human proteome. Nature 509, 575-581,
doi:10.1038/nature13302 (2014).
Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNAseq. Science 352, 189, doi:10.1126/science.aad0501 (2016).
Verfaillie, A. et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators
of the invasive cell state. Nat Commun 6, 6683, doi:10.1038/ncomms7683 (2015).
Rambow, F. et al. New Functional Signatures for Understanding Melanoma Biology from Tumor
Cell Lineage-Specific Analysis. Cell Reports 13, 840-853, doi:10.1016/j.celrep.2015.09.037 (2015).
Peres, J. & Prince, S. The T-box transcription factor, TBX3, is sufficient to promote melanoma
formation and invasion. Molecular cancer 12, 117-117, doi:10.1186/1476-4598-12-117 (2013).
Falletta, P. et al. Translation reprogramming is an evolutionarily conserved driver of phenotypic
plasticity and therapeutic resistance in melanoma. Genes Dev 31, 18-33,
doi:10.1101/gad.290940.116 (2017).
Anand, P. et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell
154, 569-582, doi:10.1016/j.cell.2013.07.013 (2013).
Duan, Q. et al. BET bromodomain inhibition suppresses innate inflammatory and profibrotic
transcriptional networks in heart failure. Sci Transl Med 9, doi:10.1126/scitranslmed.aah5084
(2017).
Lagutin, O. V. et al. Six3 repression of Wnt signaling in the anterior neuroectoderm is essential for
vertebrate forebrain development. Genes & development 17, 368-379 (2003).
Carl, M., Loosli, F. & Wittbrodt, J. Six3 inactivation reveals its essential role for the formation and
patterning of the vertebrate eye. Development 129, 4057-4063 (2002).
Steinmetz, P. R. et al. Six3 demarcates the anterior-most developing brain region in bilaterian
animals. EvoDevo 1, 14 (2010).
Peng, G. et al. Spatial Transcriptome for the Molecular Annotation of Lineage Fates and Cell
Identity in Mid-gastrula Mouse Embryo. Dev Cell 36, 681-697, doi:10.1016/j.devcel.2016.02.020
(2016).
Sherwood, R. I. et al. Prospective isolation and global gene expression analysis of definitive and
visceral endoderm. Developmental Biology 304, 541-555, (2007).
58

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63

Wang, W. et al. A single cell transcriptional roadmap for cardiopharyngeal fate diversification.
BioRxiv (2019).
Ma, P. et al. The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7mediated deubiquitination of beta-catenin. Mol Cell Biol 34, 4355-4366, doi:10.1128/MCB.0073114 (2014).
Ernst, J. & Kellis, M. Large-scale imputation of epigenomic datasets for systematic annotation of
diverse human tissues. Nat Biotechnol 33, 364-376, doi:10.1038/nbt.3157 (2015).
Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343349, doi:10.1038/nature09784 (2011).
Wu, S. F., Zhang, H. & Cairns, B. R. Genes for embryo development are packaged in blocks of
multivalent chromatin in zebrafish sperm. Genome Res 21, 578-589, doi:10.1101/gr.113167.110
(2011).
Fujikura, J. et al. Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev
16, 784-789, doi:10.1101/gad.968802 (2002).
Wilson, D., Charoensawan, V., Kummerfeld, S. K. & Teichmann, S. A. DBD--taxonomically broad
transcription factor predictions: new content and functionality. Nucleic Acids Res 36, D88-92,
doi:10.1093/nar/gkm964 (2008).
Zhang, H. M. et al. AnimalTFDB 2.0: a resource for expression, prediction and functional study of
animal transcription factors. Nucleic Acids Res 43, D76-81, doi:10.1093/nar/gku887 (2015).
Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580-585,
doi:10.1038/ng.2653 (2013).
Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology
Consortium. Nat Genet 25, 25-29, doi:10.1038/75556 (2000).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features.
Bioinformatics 26, 841-842, doi:10.1093/bioinformatics/btq033 (2010).
Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in
humans. Nature 470, 279-283, doi:10.1038/nature09692 (2011).
Clark, S. J., Lee, H. J., Smallwood, S. A., Kelsey, G. & Reik, W. Single-cell epigenomics: powerful
new methods for understanding gene regulation and cell identity. Genome Biol 17, 72,
doi:10.1186/s13059-016-0944-x (2016).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features.
Bioinformatics 26, 841-842, doi:10.1093/bioinformatics/btq033 (2010).
Loven, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153,
320-334, doi:10.1016/j.cell.2013.03.036 (2013).
Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934-947,
doi:10.1016/j.cell.2013.09.053 (2013).
McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat
Biotechnol 28, 495-501, doi:10.1038/nbt.1630 (2010).
Kharchenko, P. V., Tolstorukov, M. Y. & Park, P. J. Design and analysis of ChIP-seq experiments for
DNA-binding proteins. Nat Biotechnol 26, 1351-1359, doi:10.1038/nbt.1508 (2008).
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cisregulatory elements required for macrophage and B cell identities. Mol Cell 38, 576-589,
doi:10.1016/j.molcel.2010.05.004 (2010).
Feng, J., Liu, T., Qin, B., Zhang, Y. & Liu, X. S. Identifying ChIP-seq enrichment using MACS. Nat
Protoc 7, 1728-1740, doi:10.1038/nprot.2012.101 (2012).
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic
data across different conditions, technologies, and species. Nature Biotechnology 36, 411,
doi:10.1038/nbt.4096 (2018).
59

bioRxiv preprint doi: https://doi.org/10.1101/635516; this version posted December 20, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
under aCC-BY-NC-ND 4.0 International license.

64
65
66
67
68
69
70
71
72
73
74
75

Kiselev, V. Y. et al. SC3: consensus clustering of single-cell RNA-seq data. Nature Methods 14, 483,
doi:10.1038/nmeth.4236 (2017).
Senabouth, A. et al. ascend: R package for analysis of single-cell RNA-seq data. Gigascience 8,
doi:10.1093/gigascience/giz087 (2019).
Scrucca, L., Fop, M., Murphy, T. B. & Raftery, A. E. mclust 5: Clustering, Classification and Density
Estimation Using Gaussian Finite Mixture Models. The R journal 8, 289-317 (2016).
Haider, S. et al. BioMart Central Portal--unified access to biological data. Nucleic Acids Res 37,
W23-27, doi:10.1093/nar/gkp265 (2009).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545-15550,
doi:10.1073/pnas.0506580102 (2005).
Mandegar, M. A. et al. CRISPR Interference Efficiently Induces Specific and Reversible Gene
Silencing in Human iPSCs. Cell Stem Cell 18, 541-553, doi:10.1016/j.stem.2016.01.022 (2016).
Palpant, N. J. et al. Generating high-purity cardiac and endothelial derivatives from patterned
mesoderm using human pluripotent stem cells. Nat Protoc 12, 15-31, doi:10.1038/nprot.2016.153
(2017).
Burridge, P. W. et al. Chemically defined generation of human cardiomyocytes. Nat Methods 11,
855-860, doi:10.1038/nmeth.2999 (2014).
Jagirdar, K. et al. The NR4A2 nuclear receptor is recruited to novel nuclear foci in response to UV
irradiation and participates in nucleotide excision repair. PLoS One 8, e78075,
doi:10.1371/journal.pone.0078075 (2013).
Stolfi, A., Gandhi, S., Salek, F. & Christiaen, L. Tissue-specific genome editing in Ciona embryos by
CRISPR/Cas9. Development 141, 4115-4120, doi:10.1242/dev.114488 (2014).
Christiaen, L., Wagner, E., Shi, W. & Levine, M. Electroporation of transgenic DNAs in the sea squirt
Ciona. Cold Spring Harb Protoc 2009, pdb prot5345, doi:10.1101/pdb.prot5345 (2009).
Evans Anderson, H. & Christiaen, L. Ciona as a simple chordate model for heart development and
regeneration. Journal of cardiovascular development and disease 3, 25 (2016).

60

